###begin article-title 0
###xml 89 97 <span type="species:ncbi:9606">patients</span>
Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members
###end article-title 0
###begin p 1
###xml 0 16 0 16 <!--CREATIVE COMMONS-->
CREATIVE COMMONSThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License () which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 35 38 35 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 223 226 223 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 313 316 313 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 511 514 511 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 811 814 811 814 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 857 860 857 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 990 993 990 993 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 1028 1029 1028 1029 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1113 1116 1113 1116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 1185 1188 1185 1188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 1289 1292 1289 1292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 1444 1447 1444 1447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 1639 1642 1639 1642 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 1994 1997 1982 1985 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 670 678 <span type="species:ncbi:9606">patients</span>
###xml 748 756 <span type="species:ncbi:9606">patients</span>
###xml 843 851 <span type="species:ncbi:9606">patients</span>
###xml 1389 1396 <span type="species:ncbi:9606">patient</span>
Mutations in the progranulin gene (GRN) are an important cause of frontotemporal lobar degeneration (FTLD) with ubiquitin and TAR DNA-binding protein 43 (TDP43)-positive pathology. The clinical presentation associated with GRN mutations is heterogeneous and may include clinical probable Alzheimer's disease. All GRN mutations identified thus far cause disease through a uniform disease mechanism, i.e. the loss of functional GRN or haploinsufficiency. To determine if expression of GRN in plasma could predict GRN mutation status and could be used as a biological marker, we optimized a GRN ELISA and studied plasma samples of a consecutive clinical FTLD series of 219 patients, 70 control individuals, 72 early-onset probable Alzheimer's disease patients and nine symptomatic and 18 asymptomatic relatives of GRN mutation families. All FTLD patients with GRN loss-of-function mutations showed significantly reduced levels of GRN in plasma to about one third of the levels observed in non-GRN carriers and control individuals (P < 0.001). No overlap in distributions of GRN levels was observed between the eight GRN loss-of-function mutation carriers (range: 53-94 ng/ml) and 191 non-GRN mutation carriers (range: 115-386 ng/ml). Similar low levels of GRN were identified in asymptomatic GRN mutation carriers. Importantly, ELISA analyses also identified one probable Alzheimer's disease patient (1.4%) carrying a loss-of-function mutation in GRN. Biochemical analyses further showed that the GRN ELISA only detects full-length GRN, no intermediate granulin fragments. This study demonstrates that using a GRN ELISA in plasma, pathogenic GRN mutations can be accurately detected in symptomatic and asymptomatic carriers. The approximately75% reduction in full-length GRN, suggests an unbalanced GRN metabolism in loss-of-function mutation carriers whereby more GRN is processed into granulins. We propose that plasma GRN levels could be used as a reliable and inexpensive tool to identify all GRN mutation carriers in early-onset dementia populations and asymptomatic at-risk individuals.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 117 121 117 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">2007</xref>
###xml 349 353 349 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">2007</xref>
###xml 696 702 696 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 704 708 704 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">2001</xref>
###xml 1049 1055 1049 1055 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1057 1061 1057 1061 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">2004</xref>
###xml 1070 1076 1070 1076 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1078 1082 1078 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">2004</xref>
###xml 1094 1100 1094 1100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1102 1106 1102 1106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">2006</xref>
###xml 1116 1122 1116 1122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1124 1128 1124 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">2006</xref>
###xml 246 254 <span type="species:ncbi:9606">patients</span>
###xml 269 277 <span type="species:ncbi:9606">patients</span>
###xml 369 377 <span type="species:ncbi:9606">patients</span>
Frontotemporal lobar degeneration (FTLD) is a genetically complex neurodegenerative disorder (Rademakers and Hutton, 2007). It is the second most common form of early-onset dementia after Alzheimer's disease, accounting for 5-10% of all dementia patients and 10-20% of patients with an onset of dementia before 65 years (Graff-Radford and Woodruff, 2007). Up to 50% of patients with FTLD report a family history of dementia, suggesting a strong genetic component to the disease. The clinical symptoms associated with FTLD are diverse including behaviour and personality changes, language disorders of expression and comprehension, cognitive impairment and sometimes motor neuron disease (McKhann et al., 2001). Three clinical FTLD subtypes have been defined: behavioural variant frontotemporal dementia (bvFTD), progressive non-fluent aphasia (PNFA) and semantic dementia (SD). The most common neuropathology associated with this type of dementia is FTLD with ubiquitin- and TAR DNA-binding protein 43 (TDP-43) positive inclusions (FTLD-U) (Josephs et al., 2004; Lipton et al., 2004; Mackenzie et al., 2006; Neumann et al., 2006).
###end p 4
###begin p 5
###xml 75 78 75 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 168 174 168 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 176 180 176 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2006</xref>
###xml 188 194 188 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 196 200 196 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">2006</xref>
###xml 207 213 207 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 215 219 215 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">2006</xref>
###xml 255 258 255 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 363 369 363 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 371 376 371 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">2008a</xref>
###xml 379 382 379 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 643 646 643 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 688 691 688 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 734 740 734 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 742 747 742 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">2008b</xref>
###xml 764 770 764 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 772 776 772 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">2008</xref>
###xml 834 837 834 837 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 142 150 <span type="species:ncbi:9606">patients</span>
In 2006, we identified loss-of-function mutations in the progranulin gene (GRN) as a major cause of familial FTLD-U, explaining 25% of FTLD-U patients worldwide (Baker et al., 2006; Cruts et al., 2006; Gass et al., 2006). To date, 63 different pathogenic GRN loss-of-function mutations have been reported in 169 genealogically unrelated FTLD families (Gijselinck et al., 2008a). GRN mutations are found scattered over the gene and include a variety of genetic alterations, such as nonsense and splice-site mutations as well as small insertions and deletions leading to a shift in the normal reading frame. Recently, the first complete genomic GRN deletion and a near complete deletion of GRN exons 1-11 were also reported (Gijselinck et al., 2008b; Rovelet-Lecrux et al., 2008). Together these studies established the notion that all GRN mutations share the same pathogenic mechanism, i.e. the loss of 50% functional GRN, suggesting a haploinsufficiency disease mechanism.
###end p 5
###begin p 6
###xml 68 71 68 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 122 126 122 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">2008</xref>
###xml 280 286 280 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 288 292 288 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">2006</xref>
###xml 301 307 301 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 309 313 309 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">2007</xref>
###xml 326 332 326 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 334 338 334 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">2007</xref>
###xml 345 351 345 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 353 357 353 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">2008</xref>
###xml 438 441 438 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 596 602 596 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 604 608 604 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">2008</xref>
###xml 619 625 619 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 627 631 627 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">2007</xref>
###xml 641 647 641 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 649 653 649 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">2007</xref>
###xml 662 668 662 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 670 674 670 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">2007</xref>
###xml 687 693 687 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 695 699 695 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">2007</xref>
###xml 297 300 <span type="species:ncbi:157914">Ber</span>
###xml 485 493 <span type="species:ncbi:9606">patients</span>
The spectrum of clinical presentations associated with mutations in GRN is highly heterogeneous (van Swieten and Heutink, 2008). Behaviour changes are the most common symptoms, although prominent language impairment is a frequent occurrence during the course of the disease (Gass et al., 2006; Le Ber et al., 2007; Rademakers et al., 2007; Beck et al., 2008). Importantly, episodic memory deficits occur in the initial stage in 10-30% of GRN mutation carriers, occasionally leading to patients being diagnosed with Alzheimer's disease or an amnestic variant of mild cognitive impairment (Benussi et al., 2008; Brouwers et al., 2007; Josephs et al., 2007; Kelley et al., 2007; Rademakers et al., 2007).
###end p 6
###begin p 7
###xml 153 157 153 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">1998</xref>
###xml 439 445 439 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 447 451 447 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">2002</xref>
###xml 647 651 647 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">2003</xref>
###xml 656 662 656 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 664 668 664 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">2003</xref>
###xml 760 768 760 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 843 849 843 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 851 855 851 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">2008</xref>
GRN encodes a secreted precursor protein composed of a signal peptide sequence and 7.5 tandem repeats of a rare 12 cysteinyl motif (Bateman and Bennett, 1998). While GRN has growth factor properties and a weak anti-inflammatory effect, it can be proteolytically cleaved by extracellular proteases, such as elastase, to form a family of peptides, ranging in size from 6 to 25 kDa, called granulins, which are strongly pro-inflammatory (Zhu et al., 2002). Both GRN and the granulins are widely expressed and have been implicated in a range of biological processes including development, wound repair, inflammation and tumorigenesis (He and Bateman, 2003; He et al., 2003). The exact function of GRN in the brain still remains to be determined; however, a recent in vitro study suggested that GRN may function as a neurotrophic factor (Van Damme et al., 2008).
###end p 7
###begin p 8
###xml 74 77 74 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 187 190 187 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 354 357 354 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 487 493 487 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 495 499 495 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">1984</xref>
###xml 210 218 <span type="species:ncbi:9606">patients</span>
###xml 379 386 <span type="species:ncbi:9606">patient</span>
Based on the uniform haploinsufficiency disease mechanism associated with GRN mutations, we hypothesized that the analyses of GRN levels in plasma using an ELISA could be used to predict GRN mutation status in patients with FTLD and their asymptomatic family members. In addition, we sought to test the usefulness of a GRN ELISA in the identification of GRN mutation carriers in patient populations with other forms of early-onset dementia, such as probable Alzheimer's disease (McKhann et al., 1984).
###end p 8
###begin title 9
Methods
###end title 9
###begin title 10
###xml 0 12 <span type="species:ncbi:9606">Participants</span>
Participants
###end title 10
###begin p 11
###xml 862 868 862 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 870 874 870 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">1998</xref>
###xml 974 978 974 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">2003</xref>
###xml 1089 1095 1089 1095 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1097 1101 1097 1101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">2008</xref>
###xml 39 47 <span type="species:ncbi:9606">patients</span>
###xml 96 100 <span type="species:ncbi:162683">Mayo</span>
###xml 156 164 <span type="species:ncbi:9606">patients</span>
###xml 376 384 <span type="species:ncbi:9606">patients</span>
###xml 391 398 <span type="species:ncbi:9606">patient</span>
###xml 548 556 <span type="species:ncbi:9606">patients</span>
###xml 709 717 <span type="species:ncbi:9606">patients</span>
###xml 735 743 <span type="species:ncbi:9606">patients</span>
###xml 877 885 <span type="species:ncbi:9606">Patients</span>
###xml 1201 1209 <span type="species:ncbi:9606">patients</span>
###xml 1227 1232 <span type="species:ncbi:9606">women</span>
###xml 1238 1246 <span type="species:ncbi:9606">patients</span>
###xml 1463 1471 <span type="species:ncbi:9606">patients</span>
###xml 1725 1733 <span type="species:ncbi:9606">patients</span>
###xml 1756 1764 <span type="species:ncbi:9606">patients</span>
###xml 1832 1840 <span type="species:ncbi:9606">patients</span>
Our FTLD study cohort consisted of 219 patients from a consecutive clinical case series seen at Mayo Jacksonville by the Behavioural Neurology section. All patients agreed to be in the study and biological samples were obtained after informed consent. DNA and plasma samples were collected and stored using standard procedures. Plasma was available for 94.5% (207/219) of the patients. Each patient underwent a full neurological evaluation and all who were testable had a neuropsychological evaluation. Structural neuroimaging was performed in all patients, the majority having MRI but a few have CT. Functional imaging using either single photon emission tomography (SPECT) or PET was also performed in most patients. The majority of patients were followed over time clinically. The diagnoses of the bvFTD, SD and PNFA were made using the Neary criteria (Neary et al., 1998). Patients who had Primary Progressive Aphasia and were fluent (FA) met Mesulam criteria (Mesulam, 2003). Retrospectively, many but not all of them would meet criteria for logopenic or mixed aphasia (Gorno-Tempini et al., 2008). Those with the corticobasal syndrome (CBS) met the criteria outlined by Boeve (2007). Out of 219 patients with FTLD (50.7% women), 74 patients were diagnosed with bvFTD (including one with FTD-ALS), 33 with PNFA, 44 with SD, 42 with FA and 26 with CBS. The mean age at disease onset was 63.9 years (SD 8.3 years, range: 44-85 years). In 39.7% (87/219) of the patients a positive family history, defined as having at least one first degree relative with a history of dementia or disease in the FTLD spectrum including ALS, progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD), was observed. Twenty-one patients underwent autopsy: 16 patients showed pathological diagnoses within the FTLD spectrum, while five patients showed Alzheimer's disease at autopsy.
###end p 11
###begin p 12
###xml 180 183 180 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 276 282 276 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 284 288 284 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2006</xref>
###xml 295 301 295 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 303 307 303 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">2006</xref>
###xml 316 322 316 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 324 328 324 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">2007</xref>
###xml 341 347 341 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 349 353 349 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">2007</xref>
###xml 761 767 753 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 769 773 761 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">1984</xref>
###xml 895 898 887 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 987 993 979 985 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 995 999 987 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">2008</xref>
###xml 19 27 <span type="species:ncbi:9606">patients</span>
###xml 217 221 <span type="species:ncbi:162683">Mayo</span>
###xml 239 243 <span type="species:ncbi:162683">Mayo</span>
###xml 426 434 <span type="species:ncbi:9606">patients</span>
###xml 506 511 <span type="species:ncbi:9606">women</span>
###xml 613 618 <span type="species:ncbi:9606">women</span>
###xml 645 649 <span type="species:ncbi:162683">Mayo</span>
###xml 864 871 <span type="species:ncbi:9606">patient</span>
In addition to the patients included in the consecutive FTLD series, DNA and plasma samples of eight affected and 18 unaffected at-risk individuals from three previously published GRN mutation families ascertained at Mayo Jacksonville and Mayo Rochester were available (Baker et al., 2006; Gass et al., 2006; Kelley et al., 2007; Rademakers et al., 2007). DNA and plasma samples of 72 early-onset probable Alzheimer's disease patients (mean age at onset +/- SD: 57.9 +/- 6.4 years; range: 37-65 years; 61% women) and 70 unrelated control individuals (mean age +/- SD: 66.3 +/- 11.0 years; range: 46-85 years; 50% women) were also ascertained at Mayo Jacksonville. The clinical diagnoses of Alzheimer's disease were made using the NINCDS/ADRDA criteria (McKhann et al., 1984). In collaboration with Dr Deramecourt we further obtained plasma samples from the French patient carrying a deletion of GRN exons 1-11 and two unaffected unrelated control individuals from France (Rovelet-Lecrux et al., 2008).
###end p 12
###begin title 13
Procedures
###end title 13
###begin p 14
###xml 74 77 74 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 107 111 107 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAPT</italic>
###xml 195 201 195 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 203 207 203 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">1998</xref>
###xml 215 221 215 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 223 227 223 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2006</xref>
###xml 575 578 575 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 693 697 693 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAPT</italic>
###xml 759 765 759 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 767 771 767 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">2006</xref>
###xml 621 629 <span type="species:ncbi:9606">patients</span>
###xml 662 666 <span type="species:ncbi:162683">Mayo</span>
For sequencing analyses, all 12 coding exons and the non-coding exon 0 of GRN and exon 1 and exons 9-13 of MAPT were amplified by PCR using our previously published primers and protocols (Hutton et al., 1998; Baker et al., 2006). PCR products were purified using AMPure (Agencourt Biosciences, Beverly, MA) then sequenced in both directions using the Big Dye Terminator v3.1 Cycle Sequencing kit (Applied Biosystems, Foster City, CA). Sequencing reactions were purified using CleanSEQ (Agencourt Biosciences) and analysed on an ABI3730 Genetic Analyser (Applied Biosystems). GRN sequencing was previously performed in 64 patients from this cohort as part of the Mayo Clinic FTLD series, while MAPT sequencing was not previously performed in this cohort (Gass et al., 2006).
###end p 14
###begin p 15
###xml 51 54 51 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 218 221 218 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 361 365 361 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAPT</italic>
###xml 372 378 372 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 380 384 380 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">2006</xref>
###xml 23 31 <span type="species:ncbi:9606">patients</span>
To investigate whether patients who carry the same GRN mutation are descendants from a common founder, we did a haplotype sharing study with eight short tandem repeat (STR) markers spanning a region of 6.9 Mb flanking GRN at chromosome 17q21. The STR markers D17S1299, D17S951, D17S1860, D17S934, D17S950, D17S806, TAUPROM [an STR marker located in intron 0 of MAPT (Gass et al., 2006)] and the newly developed GRN_GT15 were PCR amplified with one fluorescently labeled primer and analysed on an automated ABI3730 DNA analyser. PCR primers used for GRN_GT15 were F: TCCCATTTCTCCCTTCTAGTTG and R: AAGTTGAGGCTGCAGGGTG. Alleles were scored using the GENOTYPER software (Applied Biosystems).
###end p 15
###begin p 16
###xml 38 41 38 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
Genotyping of control individuals for GRN variant c.415T>C (p.C139R) was performed with a TaqMan chemistry-based allelic discrimination assay, with Assay by Design probes (Applied Biosystems) and an Applied Biosystems 7900 PCR system, followed by analysis with Sequence Detection System 2.2.1 software (Applied Biosystems).
###end p 16
###begin p 17
###xml 507 508 507 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 38 43 <span type="species:ncbi:9606">human</span>
###xml 72 77 <span type="species:ncbi:9606">human</span>
###xml 580 585 <span type="species:ncbi:9606">human</span>
To determine GRN expression levels in human plasma samples, we used the human Progranulin ELISA kit (Adipogen Inc., Seoul, Korea) using a 1:100 dilution of the plasma samples in 1x diluent following manufacturer's instructions. The wash solution was aspirated after each third wash to ensure that all residual wash solution was removed. To increase accuracy all samples were analysed twice in two independent experiments using six interplate control samples for normalization. Based on our FTLD population (n = 207), the median coefficient of variation (CV) was 3.2%. Recombinant human GRN provided with the ELISA kit was used as a standard.
###end p 17
###begin p 18
###xml 215 218 215 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 189 197 <span type="species:ncbi:9606">patients</span>
For Western blot analyses, albumin depleted plasma samples (SwellGel Blue Albumin Removal Kit, Pierce, Rockford, IL) and protein samples extracted from cerebellar brain homogenates of FTLD patients with and without GRN mutations, were separated by SDS-PAGE using pre-cast 4-20% Tris-Glycine gels (Invitrogen, Carlsbad, CA) and transferred to nitrocellulose membranes. GRN levels were assessed using the GRN capture antibody and the GRN detection antibody used in the ELISA (Adipogen Inc.). GRN cleavage products were obtained by elastase treatment of recombinant GRN for 30 min at 25degreesC (Athens Research & Technology, Athens, GA).
###end p 18
###begin title 19
Statistical analyses
###end title 19
###begin p 20
###xml 225 226 225 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 482 485 480 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 541 544 539 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
GRN expression levels were compared between two groups using Mann-Whitney tests. The Kruskal-Wallis test was used to compare GRN expression across clinical FTLD subtypes. Results were considered statistically significant for P </= 0.05; no adjustments were made for multiple testing; however, results were interpreted cautiously in the light of the number of tests conducted in these exploratory analyses. Since there was no overlap in distributions of GRN expression levels in the GRN loss-of-function mutation carriers compared to the non-GRN carriers, we explored sensitivity and specificity for various cut-off points on a continuous scale by fitting normal distributions to the square root of the GRN levels. Ten thousand bootstrap samples were then obtained to construct 95% confidence intervals for sensitivity and specificity at a range of potential cut-off values.
###end p 20
###begin title 21
Results
###end title 21
###begin p 22
###xml 45 48 45 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 53 57 53 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAPT</italic>
###xml 201 205 201 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAPT</italic>
###xml 95 103 <span type="species:ncbi:9606">patients</span>
###xml 179 183 <span type="species:ncbi:162683">Mayo</span>
###xml 292 299 <span type="species:ncbi:9606">patient</span>
###xml 488 495 <span type="species:ncbi:9606">patient</span>
We performed systematic mutation analyses of GRN and MAPT through direct sequencing in all 219 patients diagnosed with FTLD from a consecutive clinical case series ascertained at Mayo Jacksonville. In MAPT, we identified the known pathogenic mutation, IVS10 + 16C>T, in intron 10 in a single patient (NGR180), who presented with personality changes at the age of 55 and was diagnosed with bvFTD. His father, paternal uncle and aunt also had early-onset dementia. Imaging analyses in this patient showed bilateral temporal atrophy on MRI as well as bilateral temporal hypometabolism on PET.
###end p 22
###begin p 23
###xml 3 6 3 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 225 232 225 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 373 380 373 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 440 443 440 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 624 627 624 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 914 917 914 917 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 951 958 951 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 960 967 960 967 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</label>
###xml 1012 1015 1012 1015 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 967 1033 967 1033 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="24">Clinical and pathological characteristics of <italic>GRN</italic> mutation carriers</p>
###xml 967 1033 967 1033 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="24">Clinical and pathological characteristics of <italic>GRN</italic> mutation carriers</p></caption>
###xml 1033 1048 1033 1048 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Patient (alias)</th>
###xml 1048 1098 1048 1098 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Predicted cDNA mutation Predicted protein mutation</th>
###xml 1098 1101 1098 1101 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Sex</th>
###xml 1101 1113 1101 1113 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Age at onset</th>
###xml 1113 1127 1113 1127 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Family history</th>
###xml 1127 1138 1127 1138 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Clinical Dx</th>
###xml 1138 1154 1138 1154 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Initial clinical</th>
###xml 1154 1177 1154 1177 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Structural neuroimaging</th>
###xml 1177 1200 1177 1200 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Functional neuroimaging</th>
###xml 1200 1209 1200 1209 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Pathology</th>
###xml 1209 1229 1209 1229 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Reference to patient</th>
###xml 1033 1229 1033 1229 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><th rowspan="1" colspan="1">Patient (alias)</th><th rowspan="1" colspan="1">Predicted cDNA mutation Predicted protein mutation</th><th rowspan="1" colspan="1">Sex</th><th rowspan="1" colspan="1">Age at onset</th><th rowspan="1" colspan="1">Family history</th><th rowspan="1" colspan="1">Clinical Dx</th><th rowspan="1" colspan="1">Initial clinical</th><th rowspan="1" colspan="1">Structural neuroimaging</th><th rowspan="1" colspan="1">Functional neuroimaging</th><th rowspan="1" colspan="1">Pathology</th><th rowspan="1" colspan="1">Reference to patient</th></tr>
###xml 1229 1229 1229 1229 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1229 1229 1229 1229 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1229 1229 1229 1229 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1229 1236 1229 1236 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(death)</th>
###xml 1236 1236 1236 1236 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1236 1236 1236 1236 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1236 1243 1236 1243 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">symptom</th>
###xml 1243 1243 1243 1243 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1243 1243 1243 1243 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1243 1243 1243 1243 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1243 1243 1243 1243 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1229 1243 1229 1243 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">(death)</th><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">symptom</th><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/></tr>
###xml 1033 1243 1033 1243 <thead xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><th rowspan="1" colspan="1">Patient (alias)</th><th rowspan="1" colspan="1">Predicted cDNA mutation Predicted protein mutation</th><th rowspan="1" colspan="1">Sex</th><th rowspan="1" colspan="1">Age at onset</th><th rowspan="1" colspan="1">Family history</th><th rowspan="1" colspan="1">Clinical Dx</th><th rowspan="1" colspan="1">Initial clinical</th><th rowspan="1" colspan="1">Structural neuroimaging</th><th rowspan="1" colspan="1">Functional neuroimaging</th><th rowspan="1" colspan="1">Pathology</th><th rowspan="1" colspan="1">Reference to patient</th></tr><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">(death)</th><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">symptom</th><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/></tr></thead>
###xml 1243 1246 1243 1246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 1243 1273 1243 1273 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" colspan="11" rowspan="1"><italic>GRN</italic> loss-of-function mutations</td>
###xml 1243 1273 1243 1273 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td colspan="11" rowspan="1"><italic>GRN</italic> loss-of-function mutations</td></tr>
###xml 1273 1279 1273 1279 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">NGR019</td>
###xml 1279 1286 1279 1286 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">c.26C&gt;A</td>
###xml 1286 1287 1286 1287 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">F</td>
###xml 1287 1289 1287 1289 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">56</td>
###xml 1289 1290 1289 1290 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Y</td>
###xml 1290 1294 1290 1294 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">PNFA</td>
###xml 1294 1301 1294 1301 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Aphasia</td>
###xml 1301 1317 1301 1317 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">MRI: perisylvian</td>
###xml 1317 1325 1317 1325 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Not done</td>
###xml 1325 1325 1325 1325 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1331 1337 1331 1337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1339 1343 1339 1343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">2006</xref>
###xml 1325 1344 1325 1344 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(Gass <italic>et al.</italic>, <xref ref-type="bibr" rid="B12">2006</xref>;</td>
###xml 1273 1344 1273 1344 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">NGR019</td><td rowspan="1" colspan="1">c.26C&gt;A</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">56</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">PNFA</td><td rowspan="1" colspan="1">Aphasia</td><td rowspan="1" colspan="1">MRI: perisylvian</td><td rowspan="1" colspan="1">Not done</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">(Gass <italic>et al.</italic>, <xref ref-type="bibr" rid="B12">2006</xref>;</td></tr>
###xml 1344 1355 1344 1355 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(11696)</td>
###xml 1355 1360 1355 1360 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">p.A9D</td>
###xml 1360 1360 1360 1360 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1360 1360 1360 1360 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1360 1360 1360 1360 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1360 1360 1360 1360 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1360 1360 1360 1360 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1360 1377 1360 1377 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(L&gt;R) atrophy</td>
###xml 1377 1377 1377 1377 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1377 1377 1377 1377 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1388 1394 1388 1394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1396 1400 1396 1400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">2007</xref>
###xml 1377 1401 1377 1401 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Kelley <italic>et al.</italic>, <xref ref-type="bibr" rid="B23">2007</xref>)</td>
###xml 1344 1401 1344 1401 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(11696)</td><td rowspan="1" colspan="1">p.A9D</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(L&gt;R) atrophy</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Kelley <italic>et al.</italic>, <xref ref-type="bibr" rid="B23">2007</xref>)</td></tr>
###xml 1401 1407 1401 1407 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">NGR001</td>
###xml 1407 1423 1407 1423 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">c.388_391delCAGT</td>
###xml 1423 1424 1423 1424 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">M</td>
###xml 1424 1431 1424 1431 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">65 (75)</td>
###xml 1431 1432 1431 1432 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">N</td>
###xml 1432 1436 1432 1436 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">PNFA</td>
###xml 1436 1443 1436 1443 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Aphasia</td>
###xml 1443 1460 1443 1460 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">MRI: temporal and</td>
###xml 1460 1468 1460 1468 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Not done</td>
###xml 1468 1482 1468 1482 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">FTLD-U (NII) +</td>
###xml 1482 1492 1482 1492 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">This study</td>
###xml 1401 1492 1401 1492 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">NGR001</td><td rowspan="1" colspan="1">c.388_391delCAGT</td><td rowspan="1" colspan="1">M</td><td rowspan="1" colspan="1">65 (75)</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1">PNFA</td><td rowspan="1" colspan="1">Aphasia</td><td rowspan="1" colspan="1">MRI: temporal and</td><td rowspan="1" colspan="1">Not done</td><td rowspan="1" colspan="1">FTLD-U (NII) +</td><td rowspan="1" colspan="1">This study</td></tr>
###xml 1492 1492 1492 1492 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1492 1505 1492 1505 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">p.Q130SfsX125</td>
###xml 1505 1505 1505 1505 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1505 1505 1505 1505 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1505 1505 1505 1505 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1505 1505 1505 1505 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1505 1505 1505 1505 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1505 1532 1505 1532 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;perisylvian (L) atrophy</td>
###xml 1532 1532 1532 1532 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1532 1537 1532 1537 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">HpScl</td>
###xml 1537 1537 1537 1537 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1492 1537 1492 1537 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.Q130SfsX125</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;perisylvian (L) atrophy</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">HpScl</td><td rowspan="1" colspan="1"/></tr>
###xml 1537 1543 1537 1543 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">NGR077</td>
###xml 1543 1559 1543 1559 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">c.388_391delCAGT</td>
###xml 1559 1560 1559 1560 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">M</td>
###xml 1560 1562 1560 1562 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">50</td>
###xml 1562 1563 1562 1563 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Y</td>
###xml 1563 1568 1563 1568 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">bvFTD</td>
###xml 1568 1579 1568 1579 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Personality</td>
###xml 1579 1595 1579 1595 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">MRI: generalized</td>
###xml 1595 1611 1595 1611 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">FDG-PET: frontal</td>
###xml 1611 1611 1611 1611 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1611 1621 1611 1621 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">This study</td>
###xml 1537 1621 1537 1621 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">NGR077</td><td rowspan="1" colspan="1">c.388_391delCAGT</td><td rowspan="1" colspan="1">M</td><td rowspan="1" colspan="1">50</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">bvFTD</td><td rowspan="1" colspan="1">Personality</td><td rowspan="1" colspan="1">MRI: generalized</td><td rowspan="1" colspan="1">FDG-PET: frontal</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">This study</td></tr>
###xml 1621 1621 1621 1621 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1621 1634 1621 1634 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">p.Q130SfsX125</td>
###xml 1634 1634 1634 1634 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1634 1634 1634 1634 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1634 1634 1634 1634 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1634 1634 1634 1634 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1634 1634 1634 1634 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1634 1645 1634 1645 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;atrophy</td>
###xml 1645 1669 1645 1669 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(L&gt;R) hypometabolism</td>
###xml 1669 1669 1669 1669 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1669 1669 1669 1669 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1621 1669 1621 1669 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.Q130SfsX125</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;atrophy</td><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(L&gt;R) hypometabolism</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr>
###xml 1669 1675 1669 1675 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">NGR228</td>
###xml 1675 1689 1675 1689 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">c.911_912insTG</td>
###xml 1689 1690 1689 1690 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">M</td>
###xml 1690 1692 1690 1692 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">63</td>
###xml 1692 1693 1692 1693 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">N</td>
###xml 1693 1698 1693 1698 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">bvFTD</td>
###xml 1698 1706 1698 1706 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Aphasia/</td>
###xml 1706 1724 1706 1724 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">MRI: frontal (L&gt;R)</td>
###xml 1724 1740 1724 1740 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">FDG-PET: frontal</td>
###xml 1740 1740 1740 1740 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1740 1750 1740 1750 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">This study</td>
###xml 1669 1750 1669 1750 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">NGR228</td><td rowspan="1" colspan="1">c.911_912insTG</td><td rowspan="1" colspan="1">M</td><td rowspan="1" colspan="1">63</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1">bvFTD</td><td rowspan="1" colspan="1">Aphasia/</td><td rowspan="1" colspan="1">MRI: frontal (L&gt;R)</td><td rowspan="1" colspan="1">FDG-PET: frontal</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">This study</td></tr>
###xml 1750 1750 1750 1750 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1750 1762 1750 1762 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">p.W304LfsX58</td>
###xml 1762 1762 1762 1762 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1762 1762 1762 1762 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1762 1762 1762 1762 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1762 1762 1762 1762 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1762 1777 1762 1777 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Personality</td>
###xml 1777 1788 1777 1788 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;atrophy</td>
###xml 1788 1812 1788 1812 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(L&gt;R) hypometabolism</td>
###xml 1812 1812 1812 1812 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1812 1812 1812 1812 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1750 1812 1750 1812 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.W304LfsX58</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Personality</td><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;atrophy</td><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(L&gt;R) hypometabolism</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr>
###xml 1812 1818 1812 1818 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">NGR192</td>
###xml 1818 1832 1818 1832 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">c.911_912insTG</td>
###xml 1832 1833 1832 1833 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">F</td>
###xml 1833 1835 1833 1835 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">49</td>
###xml 1835 1836 1835 1836 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Y</td>
###xml 1836 1838 1836 1838 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">FA</td>
###xml 1838 1845 1838 1845 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Aphasia</td>
###xml 1845 1859 1845 1859 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">MRI: parietal,</td>
###xml 1859 1880 1859 1880 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">FDG-PET: parietal and</td>
###xml 1880 1880 1880 1880 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1880 1890 1880 1890 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">This study</td>
###xml 1812 1890 1812 1890 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">NGR192</td><td rowspan="1" colspan="1">c.911_912insTG</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">49</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">FA</td><td rowspan="1" colspan="1">Aphasia</td><td rowspan="1" colspan="1">MRI: parietal,</td><td rowspan="1" colspan="1">FDG-PET: parietal and</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">This study</td></tr>
###xml 1890 1890 1890 1890 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1890 1902 1890 1902 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">p.W304LfsX58</td>
###xml 1902 1902 1902 1902 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1902 1902 1902 1902 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1902 1902 1902 1902 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1902 1902 1902 1902 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1902 1902 1902 1902 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1902 1942 1902 1942 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;perisylvian and temporal (L) atrophy</td>
###xml 1942 1973 1942 1973 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;temporal (L) hypometabolism</td>
###xml 1973 1973 1973 1973 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1973 1973 1973 1973 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1890 1973 1890 1973 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.W304LfsX58</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;perisylvian and temporal (L) atrophy</td><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;temporal (L) hypometabolism</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr>
###xml 1973 1979 1973 1979 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">NGR003</td>
###xml 1979 1988 1979 1988 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">c.998delG</td>
###xml 1988 1989 1988 1989 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">M</td>
###xml 1989 1996 1989 1996 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">65 (73)</td>
###xml 1996 1997 1996 1997 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Y</td>
###xml 1997 2001 1997 2001 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">PNFA</td>
###xml 2001 2008 2001 2008 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Aphasia</td>
###xml 2008 2024 2008 2024 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">MRI: perisylvian</td>
###xml 2024 2032 2024 2032 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Not done</td>
###xml 2032 2044 2032 2044 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">FTLD-U (NII)</td>
###xml 2050 2056 2050 2056 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 2058 2062 2058 2062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">2006</xref>
###xml 2044 2063 2044 2063 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(Gass <italic>et al.</italic>, <xref ref-type="bibr" rid="B12">2006</xref>;</td>
###xml 1973 2063 1973 2063 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">NGR003</td><td rowspan="1" colspan="1">c.998delG</td><td rowspan="1" colspan="1">M</td><td rowspan="1" colspan="1">65 (73)</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">PNFA</td><td rowspan="1" colspan="1">Aphasia</td><td rowspan="1" colspan="1">MRI: perisylvian</td><td rowspan="1" colspan="1">Not done</td><td rowspan="1" colspan="1">FTLD-U (NII)</td><td rowspan="1" colspan="1">(Gass <italic>et al.</italic>, <xref ref-type="bibr" rid="B12">2006</xref>;</td></tr>
###xml 2063 2075 2063 2075 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(PPA-1D)</td>
###xml 2075 2087 2075 2087 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">p.G333VfsX28</td>
###xml 2087 2087 2087 2087 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2087 2087 2087 2087 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2087 2087 2087 2087 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2087 2087 2087 2087 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2087 2087 2087 2087 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2087 2102 2087 2102 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(L) atrophy</td>
###xml 2102 2102 2102 2102 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2102 2109 2102 2109 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">+ HpScl</td>
###xml 2121 2127 2121 2127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 2129 2133 2129 2133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">2007</xref>
###xml 2109 2134 2109 2134 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Mesulam <italic>et al.</italic>, <xref ref-type="bibr" rid="B29">2007</xref>)</td>
###xml 2063 2134 2063 2134 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(PPA-1D)</td><td rowspan="1" colspan="1">p.G333VfsX28</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(L) atrophy</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">+ HpScl</td><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Mesulam <italic>et al.</italic>, <xref ref-type="bibr" rid="B29">2007</xref>)</td></tr>
###xml 2134 2140 2134 2140 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">NGR043</td>
###xml 2140 2149 2140 2149 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">c.1477C&gt;T</td>
###xml 2149 2150 2149 2150 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">F</td>
###xml 2150 2157 2150 2157 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">64 (69)</td>
###xml 2157 2158 2157 2158 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Y</td>
###xml 2158 2163 2158 2163 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">bvFTD</td>
###xml 2163 2174 2163 2174 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Personality</td>
###xml 2174 2187 2174 2187 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">MRI: moderate</td>
###xml 2187 2195 2187 2195 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Not done</td>
###xml 2195 2195 2195 2195 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2207 2213 2207 2213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 2215 2219 2215 2219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">2007</xref>
###xml 2195 2220 2195 2220 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(Rademakers <italic>et al.</italic>, <xref ref-type="bibr" rid="B36">2007</xref>)</td>
###xml 2134 2220 2134 2220 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">NGR043</td><td rowspan="1" colspan="1">c.1477C&gt;T</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">64 (69)</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">bvFTD</td><td rowspan="1" colspan="1">Personality</td><td rowspan="1" colspan="1">MRI: moderate</td><td rowspan="1" colspan="1">Not done</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">(Rademakers <italic>et al.</italic>, <xref ref-type="bibr" rid="B36">2007</xref>)</td></tr>
###xml 2220 2230 2220 2230 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(2619)</td>
###xml 2230 2237 2230 2237 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">p.R493X</td>
###xml 2237 2237 2237 2237 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2237 2237 2237 2237 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2237 2237 2237 2237 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2237 2237 2237 2237 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2237 2237 2237 2237 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2237 2275 2237 2275 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;frontal and temporal (L+R) atrophy</td>
###xml 2275 2275 2275 2275 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2275 2275 2275 2275 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2275 2275 2275 2275 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2220 2275 2220 2275 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(2619)</td><td rowspan="1" colspan="1">p.R493X</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;frontal and temporal (L+R) atrophy</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr>
###xml 2275 2281 2275 2281 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">NGR068</td>
###xml 2281 2290 2281 2290 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">c.1477C&gt;T</td>
###xml 2290 2291 2290 2291 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">M</td>
###xml 2291 2298 2291 2298 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">48 (50)</td>
###xml 2298 2299 2298 2299 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">N</td>
###xml 2299 2301 2299 2301 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">FA</td>
###xml 2301 2308 2301 2308 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Aphasia</td>
###xml 2308 2317 2308 2317 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">MRI: mild</td>
###xml 2317 2334 2317 2334 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">FDG-PET: temporal</td>
###xml 2334 2334 2334 2334 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2346 2352 2346 2352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 2354 2358 2354 2358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">2007</xref>
###xml 2334 2359 2334 2359 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(Rademakers <italic>et al.</italic>, <xref ref-type="bibr" rid="B36">2007</xref>)</td>
###xml 2275 2359 2275 2359 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">NGR068</td><td rowspan="1" colspan="1">c.1477C&gt;T</td><td rowspan="1" colspan="1">M</td><td rowspan="1" colspan="1">48 (50)</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1">FA</td><td rowspan="1" colspan="1">Aphasia</td><td rowspan="1" colspan="1">MRI: mild</td><td rowspan="1" colspan="1">FDG-PET: temporal</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">(Rademakers <italic>et al.</italic>, <xref ref-type="bibr" rid="B36">2007</xref>)</td></tr>
###xml 2359 2369 2359 2369 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(7756)</td>
###xml 2369 2376 2369 2376 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">p.R493X</td>
###xml 2376 2376 2376 2376 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2376 2376 2376 2376 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2376 2376 2376 2376 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2376 2376 2376 2376 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2376 2376 2376 2376 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2376 2419 2376 2419 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;ventricular enlargement in frontal horn</td>
###xml 2419 2469 2419 2469 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(L+R), frontal and parietal (L) hypometabolism</td>
###xml 2469 2469 2469 2469 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2469 2469 2469 2469 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2359 2469 2359 2469 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(7756)</td><td rowspan="1" colspan="1">p.R493X</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;ventricular enlargement in frontal horn</td><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(L+R), frontal and parietal (L) hypometabolism</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr>
###xml 2469 2475 2469 2475 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">NGR247</td>
###xml 2475 2507 2475 2507 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">c.1414-15_1590del p.A472_Q548del</td>
###xml 2507 2508 2507 2508 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">F</td>
###xml 2508 2515 2508 2515 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">79 (86)</td>
###xml 2515 2516 2515 2516 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">N</td>
###xml 2516 2518 2516 2518 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">SD</td>
###xml 2518 2524 2518 2524 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Anomia</td>
###xml 2524 2548 2524 2548 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CT: temporal atrophy (L)</td>
###xml 2548 2556 2548 2556 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Not done</td>
###xml 2556 2556 2556 2556 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2556 2566 2556 2566 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">This study</td>
###xml 2469 2566 2469 2566 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">NGR247</td><td rowspan="1" colspan="1">c.1414-15_1590del p.A472_Q548del</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">79 (86)</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1">SD</td><td rowspan="1" colspan="1">Anomia</td><td rowspan="1" colspan="1">CT: temporal atrophy (L)</td><td rowspan="1" colspan="1">Not done</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">This study</td></tr>
###xml 2566 2569 2566 2569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 2566 2610 2566 2610 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" colspan="11" rowspan="1"><italic>GRN</italic> mutations with unknown pathogenic nature</td>
###xml 2566 2610 2566 2610 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td colspan="11" rowspan="1"><italic>GRN</italic> mutations with unknown pathogenic nature</td></tr>
###xml 2610 2616 2610 2616 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">NGR022</td>
###xml 2616 2623 2616 2623 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">c.55C&gt;T</td>
###xml 2623 2624 2623 2624 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">F</td>
###xml 2624 2626 2624 2626 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">61</td>
###xml 2626 2627 2626 2627 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">N</td>
###xml 2627 2632 2627 2632 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">bvFTD</td>
###xml 2632 2643 2632 2643 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Personality</td>
###xml 2643 2659 2643 2659 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">MRI: frontal and</td>
###xml 2659 2667 2659 2667 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Not done</td>
###xml 2667 2667 2667 2667 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2673 2679 2673 2679 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 2681 2685 2681 2685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">2006</xref>
###xml 2667 2686 2667 2686 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(Gass <italic>et al.</italic>, <xref ref-type="bibr" rid="B12">2006</xref>)</td>
###xml 2610 2686 2610 2686 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">NGR022</td><td rowspan="1" colspan="1">c.55C&gt;T</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">61</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1">bvFTD</td><td rowspan="1" colspan="1">Personality</td><td rowspan="1" colspan="1">MRI: frontal and</td><td rowspan="1" colspan="1">Not done</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">(Gass <italic>et al.</italic>, <xref ref-type="bibr" rid="B12">2006</xref>)</td></tr>
###xml 2686 2686 2686 2686 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2686 2692 2686 2692 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">p.R19W</td>
###xml 2692 2692 2692 2692 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2692 2692 2692 2692 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2692 2692 2692 2692 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2692 2692 2692 2692 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2692 2692 2692 2692 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2692 2718 2692 2718 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;temporal (L+R) atrophy</td>
###xml 2718 2718 2718 2718 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2718 2718 2718 2718 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2718 2718 2718 2718 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2686 2718 2686 2718 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.R19W</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;temporal (L+R) atrophy</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr>
###xml 2724 2725 2724 2725 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 2724 2725 2724 2725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF1"><sup>a</sup></xref>
###xml 2718 2725 2718 2725 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">NGR139<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td>
###xml 2725 2733 2725 2733 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">c.415T&gt;C</td>
###xml 2733 2734 2733 2734 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">M</td>
###xml 2734 2736 2734 2736 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">76</td>
###xml 2736 2737 2736 2737 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Y</td>
###xml 2737 2739 2737 2739 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">FA</td>
###xml 2739 2746 2739 2746 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Aphasia</td>
###xml 2746 2755 2746 2755 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">MRI: mild</td>
###xml 2755 2776 2755 2776 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">FDG-PET: parietal and</td>
###xml 2776 2776 2776 2776 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2776 2786 2776 2786 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">This study</td>
###xml 2718 2786 2718 2786 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">NGR139<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">c.415T&gt;C</td><td rowspan="1" colspan="1">M</td><td rowspan="1" colspan="1">76</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">FA</td><td rowspan="1" colspan="1">Aphasia</td><td rowspan="1" colspan="1">MRI: mild</td><td rowspan="1" colspan="1">FDG-PET: parietal and</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">This study</td></tr>
###xml 2786 2786 2786 2786 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2786 2793 2786 2793 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">p.C139R</td>
###xml 2793 2793 2793 2793 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2793 2793 2793 2793 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2793 2793 2793 2793 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2793 2793 2793 2793 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2793 2793 2793 2793 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2793 2816 2793 2816 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;generalized atrophy</td>
###xml 2816 2847 2816 2847 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;temporal (L) hypometabolism</td>
###xml 2847 2847 2847 2847 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2847 2847 2847 2847 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2786 2847 2786 2847 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.C139R</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;generalized atrophy</td><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;temporal (L) hypometabolism</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr>
###xml 2847 2853 2847 2853 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">NGR221</td>
###xml 2853 2861 2853 2861 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">c.970G&gt;A</td>
###xml 2861 2862 2861 2862 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">M</td>
###xml 2862 2869 2862 2869 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">64 (70)</td>
###xml 2869 2870 2869 2870 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">N</td>
###xml 2870 2874 2870 2874 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">PNFA</td>
###xml 2874 2884 2874 2884 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Apraxia of</td>
###xml 2884 2901 2884 2901 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">MRI: temporal and</td>
###xml 2901 2909 2901 2909 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Not done</td>
###xml 2909 2912 2909 2912 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CBD</td>
###xml 2912 2922 2912 2922 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">This study</td>
###xml 2847 2922 2847 2922 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">NGR221</td><td rowspan="1" colspan="1">c.970G&gt;A</td><td rowspan="1" colspan="1">M</td><td rowspan="1" colspan="1">64 (70)</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1">PNFA</td><td rowspan="1" colspan="1">Apraxia of</td><td rowspan="1" colspan="1">MRI: temporal and</td><td rowspan="1" colspan="1">Not done</td><td rowspan="1" colspan="1">CBD</td><td rowspan="1" colspan="1">This study</td></tr>
###xml 2922 2922 2922 2922 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2922 2929 2922 2929 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">p.A324T</td>
###xml 2929 2929 2929 2929 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2929 2929 2929 2929 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2929 2929 2929 2929 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2929 2929 2929 2929 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2929 2939 2929 2939 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;speech</td>
###xml 2939 2965 2939 2965 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;parietal (L&gt;R) atrophy</td>
###xml 2965 2965 2965 2965 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2965 2965 2965 2965 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2965 2965 2965 2965 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2922 2965 2922 2965 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.A324T</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;speech</td><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;parietal (L&gt;R) atrophy</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr>
###xml 2965 2971 2965 2971 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">NGR039</td>
###xml 2971 2980 2971 2980 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">c.1297C&gt;T</td>
###xml 2980 2981 2980 2981 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">M</td>
###xml 2981 2983 2981 2983 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">66</td>
###xml 2983 2984 2983 2984 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">N</td>
###xml 2984 2988 2984 2988 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">PNFA</td>
###xml 2988 2995 2988 2995 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Aphasia</td>
###xml 2995 3010 2995 3010 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">MR: sylvian and</td>
###xml 3010 3018 3010 3018 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Not done</td>
###xml 3018 3018 3018 3018 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3024 3030 3024 3030 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 3032 3036 3032 3036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">2006</xref>
###xml 3018 3037 3018 3037 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(Gass <italic>et al.</italic>, <xref ref-type="bibr" rid="B12">2006</xref>)</td>
###xml 2965 3037 2965 3037 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">NGR039</td><td rowspan="1" colspan="1">c.1297C&gt;T</td><td rowspan="1" colspan="1">M</td><td rowspan="1" colspan="1">66</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1">PNFA</td><td rowspan="1" colspan="1">Aphasia</td><td rowspan="1" colspan="1">MR: sylvian and</td><td rowspan="1" colspan="1">Not done</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">(Gass <italic>et al.</italic>, <xref ref-type="bibr" rid="B12">2006</xref>)</td></tr>
###xml 3037 3037 3037 3037 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3037 3044 3037 3044 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">p.R433W</td>
###xml 3044 3044 3044 3044 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3044 3044 3044 3044 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3044 3044 3044 3044 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3044 3044 3044 3044 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3044 3044 3044 3044 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3044 3068 3044 3068 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;temporal (L) atrophy</td>
###xml 3068 3068 3068 3068 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3068 3068 3068 3068 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3068 3068 3068 3068 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3037 3068 3037 3068 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.R433W</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;temporal (L) atrophy</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr>
###xml 3068 3074 3068 3074 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">NGR105</td>
###xml 3074 3083 3074 3083 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">c.1297C&gt;T</td>
###xml 3083 3084 3083 3084 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">F</td>
###xml 3084 3086 3084 3086 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">61</td>
###xml 3086 3087 3086 3087 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Y</td>
###xml 3087 3089 3087 3089 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">SD</td>
###xml 3089 3095 3089 3095 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Anomia</td>
###xml 3095 3108 3095 3108 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">MRI: temporal</td>
###xml 3108 3121 3108 3121 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">FDG-PET: left</td>
###xml 3121 3121 3121 3121 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3121 3131 3121 3131 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">This study</td>
###xml 3068 3131 3068 3131 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">NGR105</td><td rowspan="1" colspan="1">c.1297C&gt;T</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">61</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">SD</td><td rowspan="1" colspan="1">Anomia</td><td rowspan="1" colspan="1">MRI: temporal</td><td rowspan="1" colspan="1">FDG-PET: left</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">This study</td></tr>
###xml 3131 3131 3131 3131 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3131 3138 3131 3138 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">p.R433W</td>
###xml 3138 3138 3138 3138 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3138 3138 3138 3138 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3138 3138 3138 3138 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3138 3138 3138 3138 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3138 3138 3138 3138 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3138 3155 3138 3155 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(L&gt;R) atrophy</td>
###xml 3155 3184 3155 3184 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;hemisphere hypometabolism</td>
###xml 3184 3184 3184 3184 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3184 3184 3184 3184 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3131 3184 3131 3184 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.R433W</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(L&gt;R) atrophy</td><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;hemisphere hypometabolism</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr>
###xml 3184 3190 3184 3190 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">NGR167</td>
###xml 3190 3199 3190 3199 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">c.1297C&gt;T</td>
###xml 3199 3200 3199 3200 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">M</td>
###xml 3200 3202 3200 3202 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">68</td>
###xml 3202 3203 3202 3203 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Y</td>
###xml 3203 3205 3203 3205 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">FA</td>
###xml 3205 3212 3205 3212 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Aphasia</td>
###xml 3212 3223 3212 3223 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">MRI: slight</td>
###xml 3223 3240 3223 3240 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">FDG-PET: temporal</td>
###xml 3240 3240 3240 3240 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3240 3250 3240 3250 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">This study</td>
###xml 3184 3250 3184 3250 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">NGR167</td><td rowspan="1" colspan="1">c.1297C&gt;T</td><td rowspan="1" colspan="1">M</td><td rowspan="1" colspan="1">68</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">FA</td><td rowspan="1" colspan="1">Aphasia</td><td rowspan="1" colspan="1">MRI: slight</td><td rowspan="1" colspan="1">FDG-PET: temporal</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">This study</td></tr>
###xml 3250 3250 3250 3250 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3250 3257 3250 3257 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">p.R433W</td>
###xml 3257 3257 3257 3257 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3257 3257 3257 3257 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3257 3257 3257 3257 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3257 3257 3257 3257 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3257 3257 3257 3257 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3257 3299 3257 3299 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;enlargement of the sylvian fissure (L)</td>
###xml 3299 3337 3299 3337 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;and perisylvian (L) hypometabolism</td>
###xml 3337 3337 3337 3337 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3337 3337 3337 3337 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3250 3337 3250 3337 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.R433W</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;enlargement of the sylvian fissure (L)</td><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;and perisylvian (L) hypometabolism</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr>
###xml 3337 3343 3337 3343 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">NGR084</td>
###xml 3343 3352 3343 3352 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">c.1341C&gt;T</td>
###xml 3352 3353 3352 3353 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">F</td>
###xml 3353 3355 3353 3355 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">64</td>
###xml 3355 3356 3355 3356 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Y</td>
###xml 3356 3361 3356 3361 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">bvFTD</td>
###xml 3361 3372 3361 3372 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Personality</td>
###xml 3372 3390 3372 3390 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">MRI: frontal (R&gt;L)</td>
###xml 3390 3406 3390 3406 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">FDG-PET: frontal</td>
###xml 3406 3406 3406 3406 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3406 3416 3406 3416 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">This study</td>
###xml 3337 3416 3337 3416 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">NGR084</td><td rowspan="1" colspan="1">c.1341C&gt;T</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">64</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">bvFTD</td><td rowspan="1" colspan="1">Personality</td><td rowspan="1" colspan="1">MRI: frontal (R&gt;L)</td><td rowspan="1" colspan="1">FDG-PET: frontal</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">This study</td></tr>
###xml 3416 3416 3416 3416 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3416 3422 3416 3422 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">p.H447</td>
###xml 3422 3422 3422 3422 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3422 3422 3422 3422 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3422 3422 3422 3422 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3422 3422 3422 3422 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3422 3422 3422 3422 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3422 3433 3422 3433 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;atrophy</td>
###xml 3433 3457 3433 3457 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(R&gt;L) hypometabolism</td>
###xml 3457 3457 3457 3457 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3457 3457 3457 3457 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3416 3457 3416 3457 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.H447</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;atrophy</td><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(R&gt;L) hypometabolism</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr>
###xml 3457 3463 3457 3463 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">NGR225</td>
###xml 3463 3472 3463 3472 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">c.1734G&gt;A</td>
###xml 3472 3473 3472 3473 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">F</td>
###xml 3473 3475 3473 3475 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">55</td>
###xml 3475 3476 3475 3476 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">N</td>
###xml 3476 3480 3476 3480 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">PNFA</td>
###xml 3480 3487 3480 3487 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Aphasia</td>
###xml 3487 3500 3487 3500 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">MRI: temporal</td>
###xml 3500 3508 3500 3508 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Not done</td>
###xml 3508 3508 3508 3508 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3508 3518 3508 3518 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">This study</td>
###xml 3457 3518 3457 3518 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">NGR225</td><td rowspan="1" colspan="1">c.1734G&gt;A</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">55</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1">PNFA</td><td rowspan="1" colspan="1">Aphasia</td><td rowspan="1" colspan="1">MRI: temporal</td><td rowspan="1" colspan="1">Not done</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">This study</td></tr>
###xml 3518 3518 3518 3518 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3518 3524 3518 3524 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">p.P578</td>
###xml 3524 3524 3524 3524 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3524 3524 3524 3524 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3524 3524 3524 3524 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3524 3524 3524 3524 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3524 3524 3524 3524 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3524 3541 3524 3541 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(L&gt;R) atrophy</td>
###xml 3541 3541 3541 3541 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3541 3541 3541 3541 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3541 3541 3541 3541 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3518 3541 3518 3541 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.P578</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(L&gt;R) atrophy</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr>
###xml 1243 3541 1243 3541 <tbody xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><td colspan="11" rowspan="1"><italic>GRN</italic> loss-of-function mutations</td></tr><tr><td rowspan="1" colspan="1">NGR019</td><td rowspan="1" colspan="1">c.26C&gt;A</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">56</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">PNFA</td><td rowspan="1" colspan="1">Aphasia</td><td rowspan="1" colspan="1">MRI: perisylvian</td><td rowspan="1" colspan="1">Not done</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">(Gass <italic>et al.</italic>, <xref ref-type="bibr" rid="B12">2006</xref>;</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(11696)</td><td rowspan="1" colspan="1">p.A9D</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(L&gt;R) atrophy</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Kelley <italic>et al.</italic>, <xref ref-type="bibr" rid="B23">2007</xref>)</td></tr><tr><td rowspan="1" colspan="1">NGR001</td><td rowspan="1" colspan="1">c.388_391delCAGT</td><td rowspan="1" colspan="1">M</td><td rowspan="1" colspan="1">65 (75)</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1">PNFA</td><td rowspan="1" colspan="1">Aphasia</td><td rowspan="1" colspan="1">MRI: temporal and</td><td rowspan="1" colspan="1">Not done</td><td rowspan="1" colspan="1">FTLD-U (NII) +</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.Q130SfsX125</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;perisylvian (L) atrophy</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">HpScl</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">NGR077</td><td rowspan="1" colspan="1">c.388_391delCAGT</td><td rowspan="1" colspan="1">M</td><td rowspan="1" colspan="1">50</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">bvFTD</td><td rowspan="1" colspan="1">Personality</td><td rowspan="1" colspan="1">MRI: generalized</td><td rowspan="1" colspan="1">FDG-PET: frontal</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.Q130SfsX125</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;atrophy</td><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(L&gt;R) hypometabolism</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">NGR228</td><td rowspan="1" colspan="1">c.911_912insTG</td><td rowspan="1" colspan="1">M</td><td rowspan="1" colspan="1">63</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1">bvFTD</td><td rowspan="1" colspan="1">Aphasia/</td><td rowspan="1" colspan="1">MRI: frontal (L&gt;R)</td><td rowspan="1" colspan="1">FDG-PET: frontal</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.W304LfsX58</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Personality</td><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;atrophy</td><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(L&gt;R) hypometabolism</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">NGR192</td><td rowspan="1" colspan="1">c.911_912insTG</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">49</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">FA</td><td rowspan="1" colspan="1">Aphasia</td><td rowspan="1" colspan="1">MRI: parietal,</td><td rowspan="1" colspan="1">FDG-PET: parietal and</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.W304LfsX58</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;perisylvian and temporal (L) atrophy</td><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;temporal (L) hypometabolism</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">NGR003</td><td rowspan="1" colspan="1">c.998delG</td><td rowspan="1" colspan="1">M</td><td rowspan="1" colspan="1">65 (73)</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">PNFA</td><td rowspan="1" colspan="1">Aphasia</td><td rowspan="1" colspan="1">MRI: perisylvian</td><td rowspan="1" colspan="1">Not done</td><td rowspan="1" colspan="1">FTLD-U (NII)</td><td rowspan="1" colspan="1">(Gass <italic>et al.</italic>, <xref ref-type="bibr" rid="B12">2006</xref>;</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(PPA-1D)</td><td rowspan="1" colspan="1">p.G333VfsX28</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(L) atrophy</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">+ HpScl</td><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Mesulam <italic>et al.</italic>, <xref ref-type="bibr" rid="B29">2007</xref>)</td></tr><tr><td rowspan="1" colspan="1">NGR043</td><td rowspan="1" colspan="1">c.1477C&gt;T</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">64 (69)</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">bvFTD</td><td rowspan="1" colspan="1">Personality</td><td rowspan="1" colspan="1">MRI: moderate</td><td rowspan="1" colspan="1">Not done</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">(Rademakers <italic>et al.</italic>, <xref ref-type="bibr" rid="B36">2007</xref>)</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(2619)</td><td rowspan="1" colspan="1">p.R493X</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;frontal and temporal (L+R) atrophy</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">NGR068</td><td rowspan="1" colspan="1">c.1477C&gt;T</td><td rowspan="1" colspan="1">M</td><td rowspan="1" colspan="1">48 (50)</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1">FA</td><td rowspan="1" colspan="1">Aphasia</td><td rowspan="1" colspan="1">MRI: mild</td><td rowspan="1" colspan="1">FDG-PET: temporal</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">(Rademakers <italic>et al.</italic>, <xref ref-type="bibr" rid="B36">2007</xref>)</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(7756)</td><td rowspan="1" colspan="1">p.R493X</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;ventricular enlargement in frontal horn</td><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(L+R), frontal and parietal (L) hypometabolism</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">NGR247</td><td rowspan="1" colspan="1">c.1414-15_1590del p.A472_Q548del</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">79 (86)</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1">SD</td><td rowspan="1" colspan="1">Anomia</td><td rowspan="1" colspan="1">CT: temporal atrophy (L)</td><td rowspan="1" colspan="1">Not done</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">This study</td></tr><tr><td colspan="11" rowspan="1"><italic>GRN</italic> mutations with unknown pathogenic nature</td></tr><tr><td rowspan="1" colspan="1">NGR022</td><td rowspan="1" colspan="1">c.55C&gt;T</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">61</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1">bvFTD</td><td rowspan="1" colspan="1">Personality</td><td rowspan="1" colspan="1">MRI: frontal and</td><td rowspan="1" colspan="1">Not done</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">(Gass <italic>et al.</italic>, <xref ref-type="bibr" rid="B12">2006</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.R19W</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;temporal (L+R) atrophy</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">NGR139<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">c.415T&gt;C</td><td rowspan="1" colspan="1">M</td><td rowspan="1" colspan="1">76</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">FA</td><td rowspan="1" colspan="1">Aphasia</td><td rowspan="1" colspan="1">MRI: mild</td><td rowspan="1" colspan="1">FDG-PET: parietal and</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.C139R</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;generalized atrophy</td><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;temporal (L) hypometabolism</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">NGR221</td><td rowspan="1" colspan="1">c.970G&gt;A</td><td rowspan="1" colspan="1">M</td><td rowspan="1" colspan="1">64 (70)</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1">PNFA</td><td rowspan="1" colspan="1">Apraxia of</td><td rowspan="1" colspan="1">MRI: temporal and</td><td rowspan="1" colspan="1">Not done</td><td rowspan="1" colspan="1">CBD</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.A324T</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;speech</td><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;parietal (L&gt;R) atrophy</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">NGR039</td><td rowspan="1" colspan="1">c.1297C&gt;T</td><td rowspan="1" colspan="1">M</td><td rowspan="1" colspan="1">66</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1">PNFA</td><td rowspan="1" colspan="1">Aphasia</td><td rowspan="1" colspan="1">MR: sylvian and</td><td rowspan="1" colspan="1">Not done</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">(Gass <italic>et al.</italic>, <xref ref-type="bibr" rid="B12">2006</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.R433W</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;temporal (L) atrophy</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">NGR105</td><td rowspan="1" colspan="1">c.1297C&gt;T</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">61</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">SD</td><td rowspan="1" colspan="1">Anomia</td><td rowspan="1" colspan="1">MRI: temporal</td><td rowspan="1" colspan="1">FDG-PET: left</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.R433W</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(L&gt;R) atrophy</td><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;hemisphere hypometabolism</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">NGR167</td><td rowspan="1" colspan="1">c.1297C&gt;T</td><td rowspan="1" colspan="1">M</td><td rowspan="1" colspan="1">68</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">FA</td><td rowspan="1" colspan="1">Aphasia</td><td rowspan="1" colspan="1">MRI: slight</td><td rowspan="1" colspan="1">FDG-PET: temporal</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.R433W</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;enlargement of the sylvian fissure (L)</td><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;and perisylvian (L) hypometabolism</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">NGR084</td><td rowspan="1" colspan="1">c.1341C&gt;T</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">64</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">bvFTD</td><td rowspan="1" colspan="1">Personality</td><td rowspan="1" colspan="1">MRI: frontal (R&gt;L)</td><td rowspan="1" colspan="1">FDG-PET: frontal</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.H447</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;atrophy</td><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(R&gt;L) hypometabolism</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">NGR225</td><td rowspan="1" colspan="1">c.1734G&gt;A</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">55</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1">PNFA</td><td rowspan="1" colspan="1">Aphasia</td><td rowspan="1" colspan="1">MRI: temporal</td><td rowspan="1" colspan="1">Not done</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.P578</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(L&gt;R) atrophy</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody>
###xml 1033 3541 1033 3541 <table xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Patient (alias)</th><th rowspan="1" colspan="1">Predicted cDNA mutation Predicted protein mutation</th><th rowspan="1" colspan="1">Sex</th><th rowspan="1" colspan="1">Age at onset</th><th rowspan="1" colspan="1">Family history</th><th rowspan="1" colspan="1">Clinical Dx</th><th rowspan="1" colspan="1">Initial clinical</th><th rowspan="1" colspan="1">Structural neuroimaging</th><th rowspan="1" colspan="1">Functional neuroimaging</th><th rowspan="1" colspan="1">Pathology</th><th rowspan="1" colspan="1">Reference to patient</th></tr><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">(death)</th><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">symptom</th><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/></tr></thead><tbody align="left"><tr><td colspan="11" rowspan="1"><italic>GRN</italic> loss-of-function mutations</td></tr><tr><td rowspan="1" colspan="1">NGR019</td><td rowspan="1" colspan="1">c.26C&gt;A</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">56</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">PNFA</td><td rowspan="1" colspan="1">Aphasia</td><td rowspan="1" colspan="1">MRI: perisylvian</td><td rowspan="1" colspan="1">Not done</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">(Gass <italic>et al.</italic>, <xref ref-type="bibr" rid="B12">2006</xref>;</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(11696)</td><td rowspan="1" colspan="1">p.A9D</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(L&gt;R) atrophy</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Kelley <italic>et al.</italic>, <xref ref-type="bibr" rid="B23">2007</xref>)</td></tr><tr><td rowspan="1" colspan="1">NGR001</td><td rowspan="1" colspan="1">c.388_391delCAGT</td><td rowspan="1" colspan="1">M</td><td rowspan="1" colspan="1">65 (75)</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1">PNFA</td><td rowspan="1" colspan="1">Aphasia</td><td rowspan="1" colspan="1">MRI: temporal and</td><td rowspan="1" colspan="1">Not done</td><td rowspan="1" colspan="1">FTLD-U (NII) +</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.Q130SfsX125</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;perisylvian (L) atrophy</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">HpScl</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">NGR077</td><td rowspan="1" colspan="1">c.388_391delCAGT</td><td rowspan="1" colspan="1">M</td><td rowspan="1" colspan="1">50</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">bvFTD</td><td rowspan="1" colspan="1">Personality</td><td rowspan="1" colspan="1">MRI: generalized</td><td rowspan="1" colspan="1">FDG-PET: frontal</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.Q130SfsX125</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;atrophy</td><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(L&gt;R) hypometabolism</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">NGR228</td><td rowspan="1" colspan="1">c.911_912insTG</td><td rowspan="1" colspan="1">M</td><td rowspan="1" colspan="1">63</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1">bvFTD</td><td rowspan="1" colspan="1">Aphasia/</td><td rowspan="1" colspan="1">MRI: frontal (L&gt;R)</td><td rowspan="1" colspan="1">FDG-PET: frontal</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.W304LfsX58</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Personality</td><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;atrophy</td><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(L&gt;R) hypometabolism</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">NGR192</td><td rowspan="1" colspan="1">c.911_912insTG</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">49</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">FA</td><td rowspan="1" colspan="1">Aphasia</td><td rowspan="1" colspan="1">MRI: parietal,</td><td rowspan="1" colspan="1">FDG-PET: parietal and</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.W304LfsX58</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;perisylvian and temporal (L) atrophy</td><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;temporal (L) hypometabolism</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">NGR003</td><td rowspan="1" colspan="1">c.998delG</td><td rowspan="1" colspan="1">M</td><td rowspan="1" colspan="1">65 (73)</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">PNFA</td><td rowspan="1" colspan="1">Aphasia</td><td rowspan="1" colspan="1">MRI: perisylvian</td><td rowspan="1" colspan="1">Not done</td><td rowspan="1" colspan="1">FTLD-U (NII)</td><td rowspan="1" colspan="1">(Gass <italic>et al.</italic>, <xref ref-type="bibr" rid="B12">2006</xref>;</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(PPA-1D)</td><td rowspan="1" colspan="1">p.G333VfsX28</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(L) atrophy</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">+ HpScl</td><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Mesulam <italic>et al.</italic>, <xref ref-type="bibr" rid="B29">2007</xref>)</td></tr><tr><td rowspan="1" colspan="1">NGR043</td><td rowspan="1" colspan="1">c.1477C&gt;T</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">64 (69)</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">bvFTD</td><td rowspan="1" colspan="1">Personality</td><td rowspan="1" colspan="1">MRI: moderate</td><td rowspan="1" colspan="1">Not done</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">(Rademakers <italic>et al.</italic>, <xref ref-type="bibr" rid="B36">2007</xref>)</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(2619)</td><td rowspan="1" colspan="1">p.R493X</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;frontal and temporal (L+R) atrophy</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">NGR068</td><td rowspan="1" colspan="1">c.1477C&gt;T</td><td rowspan="1" colspan="1">M</td><td rowspan="1" colspan="1">48 (50)</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1">FA</td><td rowspan="1" colspan="1">Aphasia</td><td rowspan="1" colspan="1">MRI: mild</td><td rowspan="1" colspan="1">FDG-PET: temporal</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">(Rademakers <italic>et al.</italic>, <xref ref-type="bibr" rid="B36">2007</xref>)</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(7756)</td><td rowspan="1" colspan="1">p.R493X</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;ventricular enlargement in frontal horn</td><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(L+R), frontal and parietal (L) hypometabolism</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">NGR247</td><td rowspan="1" colspan="1">c.1414-15_1590del p.A472_Q548del</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">79 (86)</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1">SD</td><td rowspan="1" colspan="1">Anomia</td><td rowspan="1" colspan="1">CT: temporal atrophy (L)</td><td rowspan="1" colspan="1">Not done</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">This study</td></tr><tr><td colspan="11" rowspan="1"><italic>GRN</italic> mutations with unknown pathogenic nature</td></tr><tr><td rowspan="1" colspan="1">NGR022</td><td rowspan="1" colspan="1">c.55C&gt;T</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">61</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1">bvFTD</td><td rowspan="1" colspan="1">Personality</td><td rowspan="1" colspan="1">MRI: frontal and</td><td rowspan="1" colspan="1">Not done</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">(Gass <italic>et al.</italic>, <xref ref-type="bibr" rid="B12">2006</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.R19W</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;temporal (L+R) atrophy</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">NGR139<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">c.415T&gt;C</td><td rowspan="1" colspan="1">M</td><td rowspan="1" colspan="1">76</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">FA</td><td rowspan="1" colspan="1">Aphasia</td><td rowspan="1" colspan="1">MRI: mild</td><td rowspan="1" colspan="1">FDG-PET: parietal and</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.C139R</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;generalized atrophy</td><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;temporal (L) hypometabolism</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">NGR221</td><td rowspan="1" colspan="1">c.970G&gt;A</td><td rowspan="1" colspan="1">M</td><td rowspan="1" colspan="1">64 (70)</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1">PNFA</td><td rowspan="1" colspan="1">Apraxia of</td><td rowspan="1" colspan="1">MRI: temporal and</td><td rowspan="1" colspan="1">Not done</td><td rowspan="1" colspan="1">CBD</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.A324T</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;speech</td><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;parietal (L&gt;R) atrophy</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">NGR039</td><td rowspan="1" colspan="1">c.1297C&gt;T</td><td rowspan="1" colspan="1">M</td><td rowspan="1" colspan="1">66</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1">PNFA</td><td rowspan="1" colspan="1">Aphasia</td><td rowspan="1" colspan="1">MR: sylvian and</td><td rowspan="1" colspan="1">Not done</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">(Gass <italic>et al.</italic>, <xref ref-type="bibr" rid="B12">2006</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.R433W</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;temporal (L) atrophy</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">NGR105</td><td rowspan="1" colspan="1">c.1297C&gt;T</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">61</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">SD</td><td rowspan="1" colspan="1">Anomia</td><td rowspan="1" colspan="1">MRI: temporal</td><td rowspan="1" colspan="1">FDG-PET: left</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.R433W</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(L&gt;R) atrophy</td><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;hemisphere hypometabolism</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">NGR167</td><td rowspan="1" colspan="1">c.1297C&gt;T</td><td rowspan="1" colspan="1">M</td><td rowspan="1" colspan="1">68</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">FA</td><td rowspan="1" colspan="1">Aphasia</td><td rowspan="1" colspan="1">MRI: slight</td><td rowspan="1" colspan="1">FDG-PET: temporal</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.R433W</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;enlargement of the sylvian fissure (L)</td><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;and perisylvian (L) hypometabolism</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">NGR084</td><td rowspan="1" colspan="1">c.1341C&gt;T</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">64</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">bvFTD</td><td rowspan="1" colspan="1">Personality</td><td rowspan="1" colspan="1">MRI: frontal (R&gt;L)</td><td rowspan="1" colspan="1">FDG-PET: frontal</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.H447</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;atrophy</td><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(R&gt;L) hypometabolism</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">NGR225</td><td rowspan="1" colspan="1">c.1734G&gt;A</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">55</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1">PNFA</td><td rowspan="1" colspan="1">Aphasia</td><td rowspan="1" colspan="1">MRI: temporal</td><td rowspan="1" colspan="1">Not done</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.P578</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(L&gt;R) atrophy</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table>
###xml 3541 3542 3541 3542 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 3541 4058 3541 4058 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="25"><sup>a</sup>Patient NGR139 also carries the rare 5&#8242;UTR-22C&gt;T promoter variant. PNFA = Progressive non-fluent aphasia. bvFTD = behavioural variant frontotemporal dementia. FA = Fluent aphasia. SD = Semantic dementia. CBD = Corticobasal degeneration. R = right. L = Left. MRI = Magnetic resonance imaging. CT = computerized tomography. FDG-PET = 18F-fluorodeoxyglucose positron emission tomography. FTLD-U = frontotemporal lobar degeneration with ubiquitin inclusions. NII = intranuclear inclusions. HpScl = Hippocampal sclerosis.</p>
###xml 3541 4058 3541 4058 <fn xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="TF1"><p textid="25"><sup>a</sup>Patient NGR139 also carries the rare 5&#8242;UTR-22C&gt;T promoter variant. PNFA = Progressive non-fluent aphasia. bvFTD = behavioural variant frontotemporal dementia. FA = Fluent aphasia. SD = Semantic dementia. CBD = Corticobasal degeneration. R = right. L = Left. MRI = Magnetic resonance imaging. CT = computerized tomography. FDG-PET = 18F-fluorodeoxyglucose positron emission tomography. FTLD-U = frontotemporal lobar degeneration with ubiquitin inclusions. NII = intranuclear inclusions. HpScl = Hippocampal sclerosis.</p></fn>
###xml 3541 4058 3541 4058 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><fn id="TF1"><p textid="25"><sup>a</sup>Patient NGR139 also carries the rare 5&#8242;UTR-22C&gt;T promoter variant. PNFA = Progressive non-fluent aphasia. bvFTD = behavioural variant frontotemporal dementia. FA = Fluent aphasia. SD = Semantic dementia. CBD = Corticobasal degeneration. R = right. L = Left. MRI = Magnetic resonance imaging. CT = computerized tomography. FDG-PET = 18F-fluorodeoxyglucose positron emission tomography. FTLD-U = frontotemporal lobar degeneration with ubiquitin inclusions. NII = intranuclear inclusions. HpScl = Hippocampal sclerosis.</p></fn></table-wrap-foot>
###xml 960 4058 960 4058 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T1" position="float"><label>Table 1</label><caption><p textid="24">Clinical and pathological characteristics of <italic>GRN</italic> mutation carriers</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Patient (alias)</th><th rowspan="1" colspan="1">Predicted cDNA mutation Predicted protein mutation</th><th rowspan="1" colspan="1">Sex</th><th rowspan="1" colspan="1">Age at onset</th><th rowspan="1" colspan="1">Family history</th><th rowspan="1" colspan="1">Clinical Dx</th><th rowspan="1" colspan="1">Initial clinical</th><th rowspan="1" colspan="1">Structural neuroimaging</th><th rowspan="1" colspan="1">Functional neuroimaging</th><th rowspan="1" colspan="1">Pathology</th><th rowspan="1" colspan="1">Reference to patient</th></tr><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">(death)</th><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">symptom</th><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/></tr></thead><tbody align="left"><tr><td colspan="11" rowspan="1"><italic>GRN</italic> loss-of-function mutations</td></tr><tr><td rowspan="1" colspan="1">NGR019</td><td rowspan="1" colspan="1">c.26C&gt;A</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">56</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">PNFA</td><td rowspan="1" colspan="1">Aphasia</td><td rowspan="1" colspan="1">MRI: perisylvian</td><td rowspan="1" colspan="1">Not done</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">(Gass <italic>et al.</italic>, <xref ref-type="bibr" rid="B12">2006</xref>;</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(11696)</td><td rowspan="1" colspan="1">p.A9D</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(L&gt;R) atrophy</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Kelley <italic>et al.</italic>, <xref ref-type="bibr" rid="B23">2007</xref>)</td></tr><tr><td rowspan="1" colspan="1">NGR001</td><td rowspan="1" colspan="1">c.388_391delCAGT</td><td rowspan="1" colspan="1">M</td><td rowspan="1" colspan="1">65 (75)</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1">PNFA</td><td rowspan="1" colspan="1">Aphasia</td><td rowspan="1" colspan="1">MRI: temporal and</td><td rowspan="1" colspan="1">Not done</td><td rowspan="1" colspan="1">FTLD-U (NII) +</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.Q130SfsX125</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;perisylvian (L) atrophy</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">HpScl</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">NGR077</td><td rowspan="1" colspan="1">c.388_391delCAGT</td><td rowspan="1" colspan="1">M</td><td rowspan="1" colspan="1">50</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">bvFTD</td><td rowspan="1" colspan="1">Personality</td><td rowspan="1" colspan="1">MRI: generalized</td><td rowspan="1" colspan="1">FDG-PET: frontal</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.Q130SfsX125</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;atrophy</td><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(L&gt;R) hypometabolism</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">NGR228</td><td rowspan="1" colspan="1">c.911_912insTG</td><td rowspan="1" colspan="1">M</td><td rowspan="1" colspan="1">63</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1">bvFTD</td><td rowspan="1" colspan="1">Aphasia/</td><td rowspan="1" colspan="1">MRI: frontal (L&gt;R)</td><td rowspan="1" colspan="1">FDG-PET: frontal</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.W304LfsX58</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Personality</td><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;atrophy</td><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(L&gt;R) hypometabolism</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">NGR192</td><td rowspan="1" colspan="1">c.911_912insTG</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">49</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">FA</td><td rowspan="1" colspan="1">Aphasia</td><td rowspan="1" colspan="1">MRI: parietal,</td><td rowspan="1" colspan="1">FDG-PET: parietal and</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.W304LfsX58</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;perisylvian and temporal (L) atrophy</td><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;temporal (L) hypometabolism</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">NGR003</td><td rowspan="1" colspan="1">c.998delG</td><td rowspan="1" colspan="1">M</td><td rowspan="1" colspan="1">65 (73)</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">PNFA</td><td rowspan="1" colspan="1">Aphasia</td><td rowspan="1" colspan="1">MRI: perisylvian</td><td rowspan="1" colspan="1">Not done</td><td rowspan="1" colspan="1">FTLD-U (NII)</td><td rowspan="1" colspan="1">(Gass <italic>et al.</italic>, <xref ref-type="bibr" rid="B12">2006</xref>;</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(PPA-1D)</td><td rowspan="1" colspan="1">p.G333VfsX28</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(L) atrophy</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">+ HpScl</td><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Mesulam <italic>et al.</italic>, <xref ref-type="bibr" rid="B29">2007</xref>)</td></tr><tr><td rowspan="1" colspan="1">NGR043</td><td rowspan="1" colspan="1">c.1477C&gt;T</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">64 (69)</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">bvFTD</td><td rowspan="1" colspan="1">Personality</td><td rowspan="1" colspan="1">MRI: moderate</td><td rowspan="1" colspan="1">Not done</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">(Rademakers <italic>et al.</italic>, <xref ref-type="bibr" rid="B36">2007</xref>)</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(2619)</td><td rowspan="1" colspan="1">p.R493X</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;frontal and temporal (L+R) atrophy</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">NGR068</td><td rowspan="1" colspan="1">c.1477C&gt;T</td><td rowspan="1" colspan="1">M</td><td rowspan="1" colspan="1">48 (50)</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1">FA</td><td rowspan="1" colspan="1">Aphasia</td><td rowspan="1" colspan="1">MRI: mild</td><td rowspan="1" colspan="1">FDG-PET: temporal</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">(Rademakers <italic>et al.</italic>, <xref ref-type="bibr" rid="B36">2007</xref>)</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(7756)</td><td rowspan="1" colspan="1">p.R493X</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;ventricular enlargement in frontal horn</td><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(L+R), frontal and parietal (L) hypometabolism</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">NGR247</td><td rowspan="1" colspan="1">c.1414-15_1590del p.A472_Q548del</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">79 (86)</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1">SD</td><td rowspan="1" colspan="1">Anomia</td><td rowspan="1" colspan="1">CT: temporal atrophy (L)</td><td rowspan="1" colspan="1">Not done</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">This study</td></tr><tr><td colspan="11" rowspan="1"><italic>GRN</italic> mutations with unknown pathogenic nature</td></tr><tr><td rowspan="1" colspan="1">NGR022</td><td rowspan="1" colspan="1">c.55C&gt;T</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">61</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1">bvFTD</td><td rowspan="1" colspan="1">Personality</td><td rowspan="1" colspan="1">MRI: frontal and</td><td rowspan="1" colspan="1">Not done</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">(Gass <italic>et al.</italic>, <xref ref-type="bibr" rid="B12">2006</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.R19W</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;temporal (L+R) atrophy</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">NGR139<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">c.415T&gt;C</td><td rowspan="1" colspan="1">M</td><td rowspan="1" colspan="1">76</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">FA</td><td rowspan="1" colspan="1">Aphasia</td><td rowspan="1" colspan="1">MRI: mild</td><td rowspan="1" colspan="1">FDG-PET: parietal and</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.C139R</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;generalized atrophy</td><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;temporal (L) hypometabolism</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">NGR221</td><td rowspan="1" colspan="1">c.970G&gt;A</td><td rowspan="1" colspan="1">M</td><td rowspan="1" colspan="1">64 (70)</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1">PNFA</td><td rowspan="1" colspan="1">Apraxia of</td><td rowspan="1" colspan="1">MRI: temporal and</td><td rowspan="1" colspan="1">Not done</td><td rowspan="1" colspan="1">CBD</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.A324T</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;speech</td><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;parietal (L&gt;R) atrophy</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">NGR039</td><td rowspan="1" colspan="1">c.1297C&gt;T</td><td rowspan="1" colspan="1">M</td><td rowspan="1" colspan="1">66</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1">PNFA</td><td rowspan="1" colspan="1">Aphasia</td><td rowspan="1" colspan="1">MR: sylvian and</td><td rowspan="1" colspan="1">Not done</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">(Gass <italic>et al.</italic>, <xref ref-type="bibr" rid="B12">2006</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.R433W</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;temporal (L) atrophy</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">NGR105</td><td rowspan="1" colspan="1">c.1297C&gt;T</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">61</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">SD</td><td rowspan="1" colspan="1">Anomia</td><td rowspan="1" colspan="1">MRI: temporal</td><td rowspan="1" colspan="1">FDG-PET: left</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.R433W</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(L&gt;R) atrophy</td><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;hemisphere hypometabolism</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">NGR167</td><td rowspan="1" colspan="1">c.1297C&gt;T</td><td rowspan="1" colspan="1">M</td><td rowspan="1" colspan="1">68</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">FA</td><td rowspan="1" colspan="1">Aphasia</td><td rowspan="1" colspan="1">MRI: slight</td><td rowspan="1" colspan="1">FDG-PET: temporal</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.R433W</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;enlargement of the sylvian fissure (L)</td><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;and perisylvian (L) hypometabolism</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">NGR084</td><td rowspan="1" colspan="1">c.1341C&gt;T</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">64</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">bvFTD</td><td rowspan="1" colspan="1">Personality</td><td rowspan="1" colspan="1">MRI: frontal (R&gt;L)</td><td rowspan="1" colspan="1">FDG-PET: frontal</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.H447</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;atrophy</td><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(R&gt;L) hypometabolism</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">NGR225</td><td rowspan="1" colspan="1">c.1734G&gt;A</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">55</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1">PNFA</td><td rowspan="1" colspan="1">Aphasia</td><td rowspan="1" colspan="1">MRI: temporal</td><td rowspan="1" colspan="1">Not done</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.P578</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;(L&gt;R) atrophy</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="TF1"><p textid="25"><sup>a</sup>Patient NGR139 also carries the rare 5&#8242;UTR-22C&gt;T promoter variant. PNFA = Progressive non-fluent aphasia. bvFTD = behavioural variant frontotemporal dementia. FA = Fluent aphasia. SD = Semantic dementia. CBD = Corticobasal degeneration. R = right. L = Left. MRI = Magnetic resonance imaging. CT = computerized tomography. FDG-PET = 18F-fluorodeoxyglucose positron emission tomography. FTLD-U = frontotemporal lobar degeneration with ubiquitin inclusions. NII = intranuclear inclusions. HpScl = Hippocampal sclerosis.</p></fn></table-wrap-foot></table-wrap>
###xml 95 103 <span type="species:ncbi:9606">patients</span>
###xml 206 213 <span type="species:ncbi:9606">patient</span>
###xml 353 361 <span type="species:ncbi:9606">patients</span>
###xml 829 833 <span type="species:ncbi:162683">Mayo</span>
###xml 1222 1229 <span type="species:ncbi:9606">patient</span>
In GRN, we identified five different pathogenic loss-of-function mutations in a total of eight patients with FTLD and a previously published partial deletion of exon 11, IVS10-15_Ex11 + 178del, in a single patient with FTLD (Table 1). We further identified four missense mutations, two silent mutations and one regulatory variant, 5'UTR-22C>T, in eight patients with FTLD (Table 1). With the exception of the silent mutation, p.P578, these GRN variants were previously published, however, their pathogenic nature largely remains unknown. Samples were not available from other family members to test for segregation of these GRN variants. The presence of missense mutation p.C139R (c.415C>T), which had not been identified in control individuals in previous studies, was further excluded in 248 control individuals ascertained at Mayo Jacksonville. A summary of the clinical and pathological characteristics of the GRN mutation carriers is provided in Table 1. Table 1Clinical and pathological characteristics of GRN mutation carriersPatient (alias)Predicted cDNA mutation Predicted protein mutationSexAge at onsetFamily historyClinical DxInitial clinicalStructural neuroimagingFunctional neuroimagingPathologyReference to patient(death)symptomGRN loss-of-function mutationsNGR019c.26C>AF56YPNFAAphasiaMRI: perisylvianNot done(Gass et al., 2006;    (11696)p.A9D    (L>R) atrophy    Kelley et al., 2007)NGR001c.388_391delCAGTM65 (75)NPNFAAphasiaMRI: temporal andNot doneFTLD-U (NII) +This studyp.Q130SfsX125    perisylvian (L) atrophyHpSclNGR077c.388_391delCAGTM50YbvFTDPersonalityMRI: generalizedFDG-PET: frontalThis studyp.Q130SfsX125    atrophy    (L>R) hypometabolismNGR228c.911_912insTGM63NbvFTDAphasia/MRI: frontal (L>R)FDG-PET: frontalThis studyp.W304LfsX58    Personality    atrophy    (L>R) hypometabolismNGR192c.911_912insTGF49YFAAphasiaMRI: parietal,FDG-PET: parietal andThis studyp.W304LfsX58    perisylvian and temporal (L) atrophy    temporal (L) hypometabolismNGR003c.998delGM65 (73)YPNFAAphasiaMRI: perisylvianNot doneFTLD-U (NII)(Gass et al., 2006;    (PPA-1D)p.G333VfsX28    (L) atrophy+ HpScl    Mesulam et al., 2007)NGR043c.1477C>TF64 (69)YbvFTDPersonalityMRI: moderateNot done(Rademakers et al., 2007)    (2619)p.R493X    frontal and temporal (L+R) atrophyNGR068c.1477C>TM48 (50)NFAAphasiaMRI: mildFDG-PET: temporal(Rademakers et al., 2007)    (7756)p.R493X    ventricular enlargement in frontal horn    (L+R), frontal and parietal (L) hypometabolismNGR247c.1414-15_1590del p.A472_Q548delF79 (86)NSDAnomiaCT: temporal atrophy (L)Not doneThis studyGRN mutations with unknown pathogenic natureNGR022c.55C>TF61NbvFTDPersonalityMRI: frontal andNot done(Gass et al., 2006)p.R19W    temporal (L+R) atrophyNGR139ac.415T>CM76YFAAphasiaMRI: mildFDG-PET: parietal andThis studyp.C139R    generalized atrophy    temporal (L) hypometabolismNGR221c.970G>AM64 (70)NPNFAApraxia ofMRI: temporal andNot doneCBDThis studyp.A324T    speech    parietal (L>R) atrophyNGR039c.1297C>TM66NPNFAAphasiaMR: sylvian andNot done(Gass et al., 2006)p.R433W    temporal (L) atrophyNGR105c.1297C>TF61YSDAnomiaMRI: temporalFDG-PET: leftThis studyp.R433W    (L>R) atrophy    hemisphere hypometabolismNGR167c.1297C>TM68YFAAphasiaMRI: slightFDG-PET: temporalThis studyp.R433W    enlargement of the sylvian fissure (L)    and perisylvian (L) hypometabolismNGR084c.1341C>TF64YbvFTDPersonalityMRI: frontal (R>L)FDG-PET: frontalThis studyp.H447    atrophy    (R>L) hypometabolismNGR225c.1734G>AF55NPNFAAphasiaMRI: temporalNot doneThis studyp.P578    (L>R) atrophyaPatient NGR139 also carries the rare 5'UTR-22C>T promoter variant. PNFA = Progressive non-fluent aphasia. bvFTD = behavioural variant frontotemporal dementia. FA = Fluent aphasia. SD = Semantic dementia. CBD = Corticobasal degeneration. R = right. L = Left. MRI = Magnetic resonance imaging. CT = computerized tomography. FDG-PET = 18F-fluorodeoxyglucose positron emission tomography. FTLD-U = frontotemporal lobar degeneration with ubiquitin inclusions. NII = intranuclear inclusions. HpScl = Hippocampal sclerosis.
###end p 23
###begin p 24
###xml 45 48 45 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
Clinical and pathological characteristics of GRN mutation carriers
###end p 24
###begin p 25
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
aPatient NGR139 also carries the rare 5'UTR-22C>T promoter variant. PNFA = Progressive non-fluent aphasia. bvFTD = behavioural variant frontotemporal dementia. FA = Fluent aphasia. SD = Semantic dementia. CBD = Corticobasal degeneration. R = right. L = Left. MRI = Magnetic resonance imaging. CT = computerized tomography. FDG-PET = 18F-fluorodeoxyglucose positron emission tomography. FTLD-U = frontotemporal lobar degeneration with ubiquitin inclusions. NII = intranuclear inclusions. HpScl = Hippocampal sclerosis.
###end p 25
###begin p 26
###xml 79 82 79 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 349 352 349 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 464 470 464 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 472 476 472 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">2006</xref>
###xml 139 147 <span type="species:ncbi:9606">patients</span>
###xml 246 254 <span type="species:ncbi:9606">patients</span>
###xml 385 393 <span type="species:ncbi:9606">patients</span>
Haplotype analyses using eight STR markers in a 6.9 Mb genomic region flanking GRN showed shared alleles for seven consecutive markers for patients NGR001 and NGR077 carrying p.Q130SfsX125 and shared alleles for all eight consecutive markers for patients NGR192 and NGR228 carrying p.W304LfsX58, suggesting a common genetic origin for each of these GRN mutations. A common founder for patients NGR043 and NGR068 carrying p.R493X had previously been reported (Gass et al., 2006).
###end p 26
###begin p 27
###xml 84 87 84 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 132 135 132 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 317 320 317 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 379 382 379 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 485 488 485 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 564 567 564 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 578 584 578 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 586 593 586 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 703 706 699 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 837 840 829 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 1085 1091 1077 1083 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 1421 1428 1413 1420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">Table 3</xref>
###xml 1676 1679 1664 1667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 1691 1697 1679 1685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 1767 1771 1755 1759 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAPT</italic>
###xml 1790 1798 1778 1786 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1</label>
###xml 1940 1943 1928 1931 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 1955 1956 1943 1944 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1985 1988 1973 1976 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 2000 2001 1988 1989 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 2042 2043 2030 2031 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 2155 2158 2143 2146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 2193 2196 2181 2184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 2216 2217 2204 2205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2369 2372 2357 2360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 1798 2484 1786 2472 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="28">Plasma GRN levels in FTLD patients and control individuals. Plasma GRN protein levels (ng/ml) in patients with FTLD carrying loss-of-function <italic>GRN</italic> mutations (<italic>n</italic> = 8), FTLD patients without <italic>GRN</italic> mutations (<italic>n</italic> = 191) and healthy control individuals (<italic>n</italic> = 70). Each data point represents an individual. Plasma levels are significantly decreased in loss-of-function <italic>GRN</italic> mutation carriers compared to non-<italic>GRN</italic> mutation carriers (<italic>P</italic> &lt; 0.001; Mann&#8211;Whitney test). For each group the median plasma level is indicated with a wide horizontal line. For larger groups (FTLD patients without <italic>GRN</italic> mutation carriers and healthy control individuals) 25% and 75% quantiles are shown with short horizontal lines.</p>
###xml 1798 2484 1786 2472 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="28">Plasma GRN levels in FTLD patients and control individuals. Plasma GRN protein levels (ng/ml) in patients with FTLD carrying loss-of-function <italic>GRN</italic> mutations (<italic>n</italic> = 8), FTLD patients without <italic>GRN</italic> mutations (<italic>n</italic> = 191) and healthy control individuals (<italic>n</italic> = 70). Each data point represents an individual. Plasma levels are significantly decreased in loss-of-function <italic>GRN</italic> mutation carriers compared to non-<italic>GRN</italic> mutation carriers (<italic>P</italic> &lt; 0.001; Mann&#8211;Whitney test). For each group the median plasma level is indicated with a wide horizontal line. For larger groups (FTLD patients without <italic>GRN</italic> mutation carriers and healthy control individuals) 25% and 75% quantiles are shown with short horizontal lines.</p></caption>
###xml 2484 2484 2472 2472 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="awn352f1"/>
###xml 1790 2484 1778 2472 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F1" position="float"><label>Figure 1</label><caption><p textid="28">Plasma GRN levels in FTLD patients and control individuals. Plasma GRN protein levels (ng/ml) in patients with FTLD carrying loss-of-function <italic>GRN</italic> mutations (<italic>n</italic> = 8), FTLD patients without <italic>GRN</italic> mutations (<italic>n</italic> = 191) and healthy control individuals (<italic>n</italic> = 70). Each data point represents an individual. Plasma levels are significantly decreased in loss-of-function <italic>GRN</italic> mutation carriers compared to non-<italic>GRN</italic> mutation carriers (<italic>P</italic> &lt; 0.001; Mann&#8211;Whitney test). For each group the median plasma level is indicated with a wide horizontal line. For larger groups (FTLD patients without <italic>GRN</italic> mutation carriers and healthy control individuals) 25% and 75% quantiles are shown with short horizontal lines.</p></caption><graphic xlink:href="awn352f1"/></fig>
###xml 2484 2492 2472 2480 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2</label>
###xml 2535 2538 2523 2526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 2630 2633 2618 2621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 2704 2707 2692 2695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 2784 2787 2772 2775 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 2877 2880 2865 2868 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 2983 2986 2971 2974 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 3032 3038 3020 3026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 3084 3087 3072 3075 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 3176 3179 3164 3167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 2492 3189 2480 3177 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="29">Specific plasma GRN levels in all types of <italic>GRN</italic> mutations. GRN expression is plotted for each patient with FTLD from our cohort carrying a <italic>GRN</italic> mutation. Black bars represent patients with FTLD carrying pathogenic <italic>GRN</italic> loss-of-function mutations; grey bars represent patients with FTLD carrying <italic>GRN</italic> mutations with unknown significance. The dashed line is the cut-off value for pathogenic <italic>GRN</italic> loss-of-function mutations based on the complete FTLD series and the black line indicates the minimum <italic>GRN</italic> expression identified in our control cohort (<xref ref-type="fig" rid="F1">Fig. 1</xref>). Missense mutations p.R19W and p.C139R show <italic>GRN</italic> levels below the range detected in control individuals and may induce a partial loss of <italic>GRN</italic> function.</p>
###xml 2492 3189 2480 3177 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="29">Specific plasma GRN levels in all types of <italic>GRN</italic> mutations. GRN expression is plotted for each patient with FTLD from our cohort carrying a <italic>GRN</italic> mutation. Black bars represent patients with FTLD carrying pathogenic <italic>GRN</italic> loss-of-function mutations; grey bars represent patients with FTLD carrying <italic>GRN</italic> mutations with unknown significance. The dashed line is the cut-off value for pathogenic <italic>GRN</italic> loss-of-function mutations based on the complete FTLD series and the black line indicates the minimum <italic>GRN</italic> expression identified in our control cohort (<xref ref-type="fig" rid="F1">Fig. 1</xref>). Missense mutations p.R19W and p.C139R show <italic>GRN</italic> levels below the range detected in control individuals and may induce a partial loss of <italic>GRN</italic> function.</p></caption>
###xml 3189 3189 3177 3177 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="awn352f2"/>
###xml 2484 3189 2472 3177 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F2" position="float"><label>Figure 2</label><caption><p textid="29">Specific plasma GRN levels in all types of <italic>GRN</italic> mutations. GRN expression is plotted for each patient with FTLD from our cohort carrying a <italic>GRN</italic> mutation. Black bars represent patients with FTLD carrying pathogenic <italic>GRN</italic> loss-of-function mutations; grey bars represent patients with FTLD carrying <italic>GRN</italic> mutations with unknown significance. The dashed line is the cut-off value for pathogenic <italic>GRN</italic> loss-of-function mutations based on the complete FTLD series and the black line indicates the minimum <italic>GRN</italic> expression identified in our control cohort (<xref ref-type="fig" rid="F1">Fig. 1</xref>). Missense mutations p.R19W and p.C139R show <italic>GRN</italic> levels below the range detected in control individuals and may induce a partial loss of <italic>GRN</italic> function.</p></caption><graphic xlink:href="awn352f2"/></fig>
###xml 3189 3196 3177 3184 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 2</label>
###xml 3196 3257 3184 3245 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="30">Summary of plasma GRN expression levels in patients with FTLD</p>
###xml 3196 3257 3184 3245 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="30">Summary of plasma GRN expression levels in patients with FTLD</p></caption>
###xml 3257 3257 3245 3245 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3257 3257 3245 3245 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3282 3282 3270 3270 <hr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
###xml 3257 3282 3245 3270 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" colspan="3" rowspan="1">Plasma GRN levels (ng/ml)<hr/></th>
###xml 3282 3282 3270 3270 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3257 3282 3245 3270 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th colspan="3" rowspan="1">Plasma GRN levels (ng/ml)<hr/></th><th rowspan="1" colspan="1"/></tr>
###xml 3282 3290 3270 3278 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Variable</th>
###xml 3290 3291 3278 3279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 3290 3291 3278 3279 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>N</italic></th>
###xml 3291 3297 3279 3285 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Median</th>
###xml 3297 3300 3285 3288 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">IQR</th>
###xml 3300 3305 3288 3293 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Range</th>
###xml 3305 3306 3293 3294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 3305 3312 3293 3300 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>P</italic>-value</th>
###xml 3282 3312 3270 3300 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><th rowspan="1" colspan="1">Variable</th><th rowspan="1" colspan="1"><italic>N</italic></th><th rowspan="1" colspan="1">Median</th><th rowspan="1" colspan="1">IQR</th><th rowspan="1" colspan="1">Range</th><th rowspan="1" colspan="1"><italic>P</italic>-value</th></tr>
###xml 3257 3312 3245 3300 <thead xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th colspan="3" rowspan="1">Plasma GRN levels (ng/ml)<hr/></th><th rowspan="1" colspan="1"/></tr><tr><th rowspan="1" colspan="1">Variable</th><th rowspan="1" colspan="1"><italic>N</italic></th><th rowspan="1" colspan="1">Median</th><th rowspan="1" colspan="1">IQR</th><th rowspan="1" colspan="1">Range</th><th rowspan="1" colspan="1"><italic>P</italic>-value</th></tr></thead>
###xml 3329 3332 3317 3320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 3341 3342 3329 3330 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 3341 3342 3329 3330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF2"><sup>a</sup></xref>
###xml 3312 3342 3300 3330 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" colspan="7" rowspan="1">Loss-of-function <italic>GRN</italic> mutation<xref ref-type="table-fn" rid="TF2"><sup>a</sup></xref></td>
###xml 3312 3342 3300 3330 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td colspan="7" rowspan="1">Loss-of-function <italic>GRN</italic> mutation<xref ref-type="table-fn" rid="TF2"><sup>a</sup></xref></td></tr>
###xml 3342 3349 3330 3337 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Yes</td>
###xml 3349 3350 3337 3338 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">8</td>
###xml 3350 3352 3338 3340 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">59</td>
###xml 3352 3357 3340 3345 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">57&#8211;81</td>
###xml 3357 3362 3345 3350 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">53&#8211;94</td>
###xml 3362 3368 3350 3356 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&lt;0.001</td>
###xml 3342 3368 3330 3356 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Yes</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">59</td><td rowspan="1" colspan="1">57&#8211;81</td><td rowspan="1" colspan="1">53&#8211;94</td><td rowspan="1" colspan="1">&lt;0.001</td></tr>
###xml 3368 3374 3356 3362 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;No</td>
###xml 3374 3377 3362 3365 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">191</td>
###xml 3377 3380 3365 3368 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">213</td>
###xml 3380 3387 3368 3375 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">186&#8211;249</td>
###xml 3387 3394 3375 3382 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">115&#8211;386</td>
###xml 3394 3394 3382 3382 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3368 3394 3356 3382 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;No</td><td rowspan="1" colspan="1">191</td><td rowspan="1" colspan="1">213</td><td rowspan="1" colspan="1">186&#8211;249</td><td rowspan="1" colspan="1">115&#8211;386</td><td rowspan="1" colspan="1"/></tr>
###xml 3400 3401 3388 3389 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 3400 3401 3388 3389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF3"><sup>b</sup></xref>
###xml 3394 3401 3382 3389 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" colspan="7" rowspan="1">Gender<xref ref-type="table-fn" rid="TF3"><sup>b</sup></xref></td>
###xml 3394 3401 3382 3389 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td colspan="7" rowspan="1">Gender<xref ref-type="table-fn" rid="TF3"><sup>b</sup></xref></td></tr>
###xml 3401 3409 3389 3397 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Male</td>
###xml 3409 3411 3397 3399 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">95</td>
###xml 3411 3414 3399 3402 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">203</td>
###xml 3414 3421 3402 3409 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">183&#8211;233</td>
###xml 3421 3428 3409 3416 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">130&#8211;370</td>
###xml 3428 3434 3416 3422 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.0011</td>
###xml 3401 3434 3389 3422 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Male</td><td rowspan="1" colspan="1">95</td><td rowspan="1" colspan="1">203</td><td rowspan="1" colspan="1">183&#8211;233</td><td rowspan="1" colspan="1">130&#8211;370</td><td rowspan="1" colspan="1">0.0011</td></tr>
###xml 3434 3444 3422 3432 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Female</td>
###xml 3444 3446 3432 3434 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">96</td>
###xml 3446 3449 3434 3437 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">233</td>
###xml 3449 3456 3437 3444 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">196&#8211;258</td>
###xml 3456 3463 3444 3451 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">115&#8211;386</td>
###xml 3463 3463 3451 3451 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3434 3463 3422 3451 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Female</td><td rowspan="1" colspan="1">96</td><td rowspan="1" colspan="1">233</td><td rowspan="1" colspan="1">196&#8211;258</td><td rowspan="1" colspan="1">115&#8211;386</td><td rowspan="1" colspan="1"/></tr>
###xml 3477 3478 3465 3466 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 3477 3478 3465 3466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF3"><sup>b</sup></xref>
###xml 3463 3478 3451 3466 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" colspan="7" rowspan="1">Family history<xref ref-type="table-fn" rid="TF3"><sup>b</sup></xref></td>
###xml 3463 3478 3451 3466 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td colspan="7" rowspan="1">Family history<xref ref-type="table-fn" rid="TF3"><sup>b</sup></xref></td></tr>
###xml 3478 3485 3466 3473 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Yes</td>
###xml 3485 3487 3473 3475 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">74</td>
###xml 3487 3490 3475 3478 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">219</td>
###xml 3490 3497 3478 3485 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">185&#8211;249</td>
###xml 3497 3504 3485 3492 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">115&#8211;386</td>
###xml 3504 3508 3492 3496 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.80</td>
###xml 3478 3508 3466 3496 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Yes</td><td rowspan="1" colspan="1">74</td><td rowspan="1" colspan="1">219</td><td rowspan="1" colspan="1">185&#8211;249</td><td rowspan="1" colspan="1">115&#8211;386</td><td rowspan="1" colspan="1">0.80</td></tr>
###xml 3508 3514 3496 3502 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;No</td>
###xml 3514 3517 3502 3505 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">117</td>
###xml 3517 3520 3505 3508 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">211</td>
###xml 3520 3527 3508 3515 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">186&#8211;250</td>
###xml 3527 3534 3515 3522 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">130&#8211;307</td>
###xml 3534 3534 3522 3522 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3508 3534 3496 3522 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;No</td><td rowspan="1" colspan="1">117</td><td rowspan="1" colspan="1">211</td><td rowspan="1" colspan="1">186&#8211;250</td><td rowspan="1" colspan="1">130&#8211;307</td><td rowspan="1" colspan="1"/></tr>
###xml 3556 3557 3544 3545 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 3556 3557 3544 3545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF3"><sup>b</sup></xref>
###xml 3534 3557 3522 3545 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" colspan="7" rowspan="1">Clinical FTLD subtypes<xref ref-type="table-fn" rid="TF3"><sup>b</sup></xref></td>
###xml 3534 3557 3522 3545 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td colspan="7" rowspan="1">Clinical FTLD subtypes<xref ref-type="table-fn" rid="TF3"><sup>b</sup></xref></td></tr>
###xml 3557 3566 3545 3554 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;bvFTD</td>
###xml 3566 3568 3554 3556 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">62</td>
###xml 3568 3571 3556 3559 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">218</td>
###xml 3571 3578 3559 3566 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">189&#8211;258</td>
###xml 3578 3585 3566 3573 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">143&#8211;370</td>
###xml 3585 3589 3573 3577 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.61</td>
###xml 3557 3589 3545 3577 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;bvFTD</td><td rowspan="1" colspan="1">62</td><td rowspan="1" colspan="1">218</td><td rowspan="1" colspan="1">189&#8211;258</td><td rowspan="1" colspan="1">143&#8211;370</td><td rowspan="1" colspan="1">0.61</td></tr>
###xml 3589 3597 3577 3585 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;PNFA</td>
###xml 3597 3599 3585 3587 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">27</td>
###xml 3599 3602 3587 3590 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">216</td>
###xml 3602 3609 3590 3597 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">187&#8211;260</td>
###xml 3609 3616 3597 3604 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">115&#8211;386</td>
###xml 3616 3616 3604 3604 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3589 3616 3577 3604 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;PNFA</td><td rowspan="1" colspan="1">27</td><td rowspan="1" colspan="1">216</td><td rowspan="1" colspan="1">187&#8211;260</td><td rowspan="1" colspan="1">115&#8211;386</td><td rowspan="1" colspan="1"/></tr>
###xml 3616 3622 3604 3610 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;SD</td>
###xml 3622 3624 3610 3612 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">40</td>
###xml 3624 3627 3612 3615 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">212</td>
###xml 3627 3634 3615 3622 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">187&#8211;235</td>
###xml 3634 3641 3622 3629 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">137&#8211;278</td>
###xml 3641 3641 3629 3629 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3616 3641 3604 3629 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;SD</td><td rowspan="1" colspan="1">40</td><td rowspan="1" colspan="1">212</td><td rowspan="1" colspan="1">187&#8211;235</td><td rowspan="1" colspan="1">137&#8211;278</td><td rowspan="1" colspan="1"/></tr>
###xml 3641 3647 3629 3635 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;FA</td>
###xml 3647 3649 3635 3637 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">37</td>
###xml 3649 3652 3637 3640 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">205</td>
###xml 3652 3659 3640 3647 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">180&#8211;248</td>
###xml 3659 3666 3647 3654 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">127&#8211;310</td>
###xml 3666 3666 3654 3654 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3641 3666 3629 3654 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;FA</td><td rowspan="1" colspan="1">37</td><td rowspan="1" colspan="1">205</td><td rowspan="1" colspan="1">180&#8211;248</td><td rowspan="1" colspan="1">127&#8211;310</td><td rowspan="1" colspan="1"/></tr>
###xml 3666 3673 3654 3661 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;CBS</td>
###xml 3673 3675 3661 3663 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">25</td>
###xml 3675 3678 3663 3666 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">230</td>
###xml 3678 3685 3666 3673 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">188&#8211;249</td>
###xml 3685 3692 3673 3680 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">130&#8211;360</td>
###xml 3692 3692 3680 3680 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 3666 3692 3654 3680 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;CBS</td><td rowspan="1" colspan="1">25</td><td rowspan="1" colspan="1">230</td><td rowspan="1" colspan="1">188&#8211;249</td><td rowspan="1" colspan="1">130&#8211;360</td><td rowspan="1" colspan="1"/></tr>
###xml 3312 3692 3300 3680 <tbody xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><td colspan="7" rowspan="1">Loss-of-function <italic>GRN</italic> mutation<xref ref-type="table-fn" rid="TF2"><sup>a</sup></xref></td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Yes</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">59</td><td rowspan="1" colspan="1">57&#8211;81</td><td rowspan="1" colspan="1">53&#8211;94</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;No</td><td rowspan="1" colspan="1">191</td><td rowspan="1" colspan="1">213</td><td rowspan="1" colspan="1">186&#8211;249</td><td rowspan="1" colspan="1">115&#8211;386</td><td rowspan="1" colspan="1"/></tr><tr><td colspan="7" rowspan="1">Gender<xref ref-type="table-fn" rid="TF3"><sup>b</sup></xref></td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Male</td><td rowspan="1" colspan="1">95</td><td rowspan="1" colspan="1">203</td><td rowspan="1" colspan="1">183&#8211;233</td><td rowspan="1" colspan="1">130&#8211;370</td><td rowspan="1" colspan="1">0.0011</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Female</td><td rowspan="1" colspan="1">96</td><td rowspan="1" colspan="1">233</td><td rowspan="1" colspan="1">196&#8211;258</td><td rowspan="1" colspan="1">115&#8211;386</td><td rowspan="1" colspan="1"/></tr><tr><td colspan="7" rowspan="1">Family history<xref ref-type="table-fn" rid="TF3"><sup>b</sup></xref></td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Yes</td><td rowspan="1" colspan="1">74</td><td rowspan="1" colspan="1">219</td><td rowspan="1" colspan="1">185&#8211;249</td><td rowspan="1" colspan="1">115&#8211;386</td><td rowspan="1" colspan="1">0.80</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;No</td><td rowspan="1" colspan="1">117</td><td rowspan="1" colspan="1">211</td><td rowspan="1" colspan="1">186&#8211;250</td><td rowspan="1" colspan="1">130&#8211;307</td><td rowspan="1" colspan="1"/></tr><tr><td colspan="7" rowspan="1">Clinical FTLD subtypes<xref ref-type="table-fn" rid="TF3"><sup>b</sup></xref></td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;bvFTD</td><td rowspan="1" colspan="1">62</td><td rowspan="1" colspan="1">218</td><td rowspan="1" colspan="1">189&#8211;258</td><td rowspan="1" colspan="1">143&#8211;370</td><td rowspan="1" colspan="1">0.61</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;PNFA</td><td rowspan="1" colspan="1">27</td><td rowspan="1" colspan="1">216</td><td rowspan="1" colspan="1">187&#8211;260</td><td rowspan="1" colspan="1">115&#8211;386</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;SD</td><td rowspan="1" colspan="1">40</td><td rowspan="1" colspan="1">212</td><td rowspan="1" colspan="1">187&#8211;235</td><td rowspan="1" colspan="1">137&#8211;278</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;FA</td><td rowspan="1" colspan="1">37</td><td rowspan="1" colspan="1">205</td><td rowspan="1" colspan="1">180&#8211;248</td><td rowspan="1" colspan="1">127&#8211;310</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;CBS</td><td rowspan="1" colspan="1">25</td><td rowspan="1" colspan="1">230</td><td rowspan="1" colspan="1">188&#8211;249</td><td rowspan="1" colspan="1">130&#8211;360</td><td rowspan="1" colspan="1"/></tr></tbody>
###xml 3257 3692 3245 3680 <table xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th colspan="3" rowspan="1">Plasma GRN levels (ng/ml)<hr/></th><th rowspan="1" colspan="1"/></tr><tr><th rowspan="1" colspan="1">Variable</th><th rowspan="1" colspan="1"><italic>N</italic></th><th rowspan="1" colspan="1">Median</th><th rowspan="1" colspan="1">IQR</th><th rowspan="1" colspan="1">Range</th><th rowspan="1" colspan="1"><italic>P</italic>-value</th></tr></thead><tbody align="left"><tr><td colspan="7" rowspan="1">Loss-of-function <italic>GRN</italic> mutation<xref ref-type="table-fn" rid="TF2"><sup>a</sup></xref></td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Yes</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">59</td><td rowspan="1" colspan="1">57&#8211;81</td><td rowspan="1" colspan="1">53&#8211;94</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;No</td><td rowspan="1" colspan="1">191</td><td rowspan="1" colspan="1">213</td><td rowspan="1" colspan="1">186&#8211;249</td><td rowspan="1" colspan="1">115&#8211;386</td><td rowspan="1" colspan="1"/></tr><tr><td colspan="7" rowspan="1">Gender<xref ref-type="table-fn" rid="TF3"><sup>b</sup></xref></td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Male</td><td rowspan="1" colspan="1">95</td><td rowspan="1" colspan="1">203</td><td rowspan="1" colspan="1">183&#8211;233</td><td rowspan="1" colspan="1">130&#8211;370</td><td rowspan="1" colspan="1">0.0011</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Female</td><td rowspan="1" colspan="1">96</td><td rowspan="1" colspan="1">233</td><td rowspan="1" colspan="1">196&#8211;258</td><td rowspan="1" colspan="1">115&#8211;386</td><td rowspan="1" colspan="1"/></tr><tr><td colspan="7" rowspan="1">Family history<xref ref-type="table-fn" rid="TF3"><sup>b</sup></xref></td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Yes</td><td rowspan="1" colspan="1">74</td><td rowspan="1" colspan="1">219</td><td rowspan="1" colspan="1">185&#8211;249</td><td rowspan="1" colspan="1">115&#8211;386</td><td rowspan="1" colspan="1">0.80</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;No</td><td rowspan="1" colspan="1">117</td><td rowspan="1" colspan="1">211</td><td rowspan="1" colspan="1">186&#8211;250</td><td rowspan="1" colspan="1">130&#8211;307</td><td rowspan="1" colspan="1"/></tr><tr><td colspan="7" rowspan="1">Clinical FTLD subtypes<xref ref-type="table-fn" rid="TF3"><sup>b</sup></xref></td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;bvFTD</td><td rowspan="1" colspan="1">62</td><td rowspan="1" colspan="1">218</td><td rowspan="1" colspan="1">189&#8211;258</td><td rowspan="1" colspan="1">143&#8211;370</td><td rowspan="1" colspan="1">0.61</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;PNFA</td><td rowspan="1" colspan="1">27</td><td rowspan="1" colspan="1">216</td><td rowspan="1" colspan="1">187&#8211;260</td><td rowspan="1" colspan="1">115&#8211;386</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;SD</td><td rowspan="1" colspan="1">40</td><td rowspan="1" colspan="1">212</td><td rowspan="1" colspan="1">187&#8211;235</td><td rowspan="1" colspan="1">137&#8211;278</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;FA</td><td rowspan="1" colspan="1">37</td><td rowspan="1" colspan="1">205</td><td rowspan="1" colspan="1">180&#8211;248</td><td rowspan="1" colspan="1">127&#8211;310</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;CBS</td><td rowspan="1" colspan="1">25</td><td rowspan="1" colspan="1">230</td><td rowspan="1" colspan="1">188&#8211;249</td><td rowspan="1" colspan="1">130&#8211;360</td><td rowspan="1" colspan="1"/></tr></tbody></table>
###xml 3692 3693 3680 3681 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 3711 3714 3699 3702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 3692 3770 3680 3758 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="31"><sup>a</sup>Patients carrying <italic>GRN</italic> mutations with unknown pathogenic nature were excluded.</p>
###xml 3692 3770 3680 3758 <fn xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="TF2"><p textid="31"><sup>a</sup>Patients carrying <italic>GRN</italic> mutations with unknown pathogenic nature were excluded.</p></fn>
###xml 3770 3771 3758 3759 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 3789 3792 3777 3780 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 3770 3817 3758 3805 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="32"><sup>b</sup>Patients carrying <italic>GRN</italic> mutations were excluded.</p>
###xml 3770 3817 3758 3805 <fn xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="TF3"><p textid="32"><sup>b</sup>Patients carrying <italic>GRN</italic> mutations were excluded.</p></fn>
###xml 3692 3817 3680 3805 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><fn id="TF2"><p textid="31"><sup>a</sup>Patients carrying <italic>GRN</italic> mutations with unknown pathogenic nature were excluded.</p></fn><fn id="TF3"><p textid="32"><sup>b</sup>Patients carrying <italic>GRN</italic> mutations were excluded.</p></fn></table-wrap-foot>
###xml 3189 3817 3177 3805 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T2" position="float"><label>Table 2</label><caption><p textid="30">Summary of plasma GRN expression levels in patients with FTLD</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th colspan="3" rowspan="1">Plasma GRN levels (ng/ml)<hr/></th><th rowspan="1" colspan="1"/></tr><tr><th rowspan="1" colspan="1">Variable</th><th rowspan="1" colspan="1"><italic>N</italic></th><th rowspan="1" colspan="1">Median</th><th rowspan="1" colspan="1">IQR</th><th rowspan="1" colspan="1">Range</th><th rowspan="1" colspan="1"><italic>P</italic>-value</th></tr></thead><tbody align="left"><tr><td colspan="7" rowspan="1">Loss-of-function <italic>GRN</italic> mutation<xref ref-type="table-fn" rid="TF2"><sup>a</sup></xref></td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Yes</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">59</td><td rowspan="1" colspan="1">57&#8211;81</td><td rowspan="1" colspan="1">53&#8211;94</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;No</td><td rowspan="1" colspan="1">191</td><td rowspan="1" colspan="1">213</td><td rowspan="1" colspan="1">186&#8211;249</td><td rowspan="1" colspan="1">115&#8211;386</td><td rowspan="1" colspan="1"/></tr><tr><td colspan="7" rowspan="1">Gender<xref ref-type="table-fn" rid="TF3"><sup>b</sup></xref></td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Male</td><td rowspan="1" colspan="1">95</td><td rowspan="1" colspan="1">203</td><td rowspan="1" colspan="1">183&#8211;233</td><td rowspan="1" colspan="1">130&#8211;370</td><td rowspan="1" colspan="1">0.0011</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Female</td><td rowspan="1" colspan="1">96</td><td rowspan="1" colspan="1">233</td><td rowspan="1" colspan="1">196&#8211;258</td><td rowspan="1" colspan="1">115&#8211;386</td><td rowspan="1" colspan="1"/></tr><tr><td colspan="7" rowspan="1">Family history<xref ref-type="table-fn" rid="TF3"><sup>b</sup></xref></td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Yes</td><td rowspan="1" colspan="1">74</td><td rowspan="1" colspan="1">219</td><td rowspan="1" colspan="1">185&#8211;249</td><td rowspan="1" colspan="1">115&#8211;386</td><td rowspan="1" colspan="1">0.80</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;No</td><td rowspan="1" colspan="1">117</td><td rowspan="1" colspan="1">211</td><td rowspan="1" colspan="1">186&#8211;250</td><td rowspan="1" colspan="1">130&#8211;307</td><td rowspan="1" colspan="1"/></tr><tr><td colspan="7" rowspan="1">Clinical FTLD subtypes<xref ref-type="table-fn" rid="TF3"><sup>b</sup></xref></td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;bvFTD</td><td rowspan="1" colspan="1">62</td><td rowspan="1" colspan="1">218</td><td rowspan="1" colspan="1">189&#8211;258</td><td rowspan="1" colspan="1">143&#8211;370</td><td rowspan="1" colspan="1">0.61</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;PNFA</td><td rowspan="1" colspan="1">27</td><td rowspan="1" colspan="1">216</td><td rowspan="1" colspan="1">187&#8211;260</td><td rowspan="1" colspan="1">115&#8211;386</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;SD</td><td rowspan="1" colspan="1">40</td><td rowspan="1" colspan="1">212</td><td rowspan="1" colspan="1">187&#8211;235</td><td rowspan="1" colspan="1">137&#8211;278</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;FA</td><td rowspan="1" colspan="1">37</td><td rowspan="1" colspan="1">205</td><td rowspan="1" colspan="1">180&#8211;248</td><td rowspan="1" colspan="1">127&#8211;310</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;CBS</td><td rowspan="1" colspan="1">25</td><td rowspan="1" colspan="1">230</td><td rowspan="1" colspan="1">188&#8211;249</td><td rowspan="1" colspan="1">130&#8211;360</td><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="TF2"><p textid="31"><sup>a</sup>Patients carrying <italic>GRN</italic> mutations with unknown pathogenic nature were excluded.</p></fn><fn id="TF3"><p textid="32"><sup>b</sup>Patients carrying <italic>GRN</italic> mutations were excluded.</p></fn></table-wrap-foot></table-wrap>
###xml 3817 3824 3805 3812 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 3</label>
###xml 3869 3872 3857 3860 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 3824 3915 3812 3903 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="33">Estimated sensitivity and specificity of the <italic>GRN</italic> ELISA assay using different cut-off values</p>
###xml 3824 3915 3812 3903 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="33">Estimated sensitivity and specificity of the <italic>GRN</italic> ELISA assay using different cut-off values</p></caption>
###xml 3915 3949 3903 3937 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Plasma GRN level cut-point (ng/ml)</th>
###xml 3969 3970 3957 3958 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 3969 3970 3957 3958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF4"><sup>a</sup></xref>
###xml 3949 3970 3937 3958 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" colspan="2" rowspan="1">Sensitivity (95% CI)<xref ref-type="table-fn" rid="TF4"><sup>a</sup></xref></th>
###xml 3990 3991 3978 3979 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 3990 3991 3978 3979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF4"><sup>a</sup></xref>
###xml 3970 3991 3958 3979 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" colspan="2" rowspan="1">Specificity (95% CI)<xref ref-type="table-fn" rid="TF4"><sup>a</sup></xref></th>
###xml 3915 3991 3903 3979 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><th rowspan="1" colspan="1">Plasma GRN level cut-point (ng/ml)</th><th colspan="2" rowspan="1">Sensitivity (95% CI)<xref ref-type="table-fn" rid="TF4"><sup>a</sup></xref></th><th colspan="2" rowspan="1">Specificity (95% CI)<xref ref-type="table-fn" rid="TF4"><sup>a</sup></xref></th></tr>
###xml 3915 3991 3903 3979 <thead xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><th rowspan="1" colspan="1">Plasma GRN level cut-point (ng/ml)</th><th colspan="2" rowspan="1">Sensitivity (95% CI)<xref ref-type="table-fn" rid="TF4"><sup>a</sup></xref></th><th colspan="2" rowspan="1">Specificity (95% CI)<xref ref-type="table-fn" rid="TF4"><sup>a</sup></xref></th></tr></thead>
###xml 3991 3994 3979 3982 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">100</td>
###xml 3994 3999 3982 3987 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">97.42</td>
###xml 3999 4010 3987 3998 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(86.90&#8211;100)</td>
###xml 4010 4015 3998 4003 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">99.88</td>
###xml 4015 4028 4003 4016 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(99.66&#8211;99.97)</td>
###xml 3991 4028 3979 4016 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">100</td><td rowspan="1" colspan="1">97.42</td><td rowspan="1" colspan="1">(86.90&#8211;100)</td><td rowspan="1" colspan="1">99.88</td><td rowspan="1" colspan="1">(99.66&#8211;99.97)</td></tr>
###xml 4028 4031 4016 4019 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">105</td>
###xml 4031 4036 4019 4024 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">98.64</td>
###xml 4036 4047 4024 4035 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(90.67&#8211;100)</td>
###xml 4047 4052 4035 4040 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">99.80</td>
###xml 4052 4065 4040 4053 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(99.48&#8211;99.94)</td>
###xml 4028 4065 4016 4053 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">105</td><td rowspan="1" colspan="1">98.64</td><td rowspan="1" colspan="1">(90.67&#8211;100)</td><td rowspan="1" colspan="1">99.80</td><td rowspan="1" colspan="1">(99.48&#8211;99.94)</td></tr>
###xml 4065 4068 4053 4056 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">110</td>
###xml 4068 4073 4056 4061 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">99.32</td>
###xml 4073 4084 4061 4072 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(93.37&#8211;100)</td>
###xml 4084 4089 4072 4077 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">99.67</td>
###xml 4089 4102 4077 4090 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(99.23&#8211;99.89)</td>
###xml 4065 4102 4053 4090 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">110</td><td rowspan="1" colspan="1">99.32</td><td rowspan="1" colspan="1">(93.37&#8211;100)</td><td rowspan="1" colspan="1">99.67</td><td rowspan="1" colspan="1">(99.23&#8211;99.89)</td></tr>
###xml 4102 4105 4090 4093 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">112</td>
###xml 4105 4110 4093 4098 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">99.49</td>
###xml 4110 4121 4098 4109 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(94.62&#8211;100)</td>
###xml 4121 4126 4109 4114 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">99.61</td>
###xml 4126 4139 4114 4127 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(99.87&#8211;99.10)</td>
###xml 4102 4139 4090 4127 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">112</td><td rowspan="1" colspan="1">99.49</td><td rowspan="1" colspan="1">(94.62&#8211;100)</td><td rowspan="1" colspan="1">99.61</td><td rowspan="1" colspan="1">(99.87&#8211;99.10)</td></tr>
###xml 4139 4142 4127 4130 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">115</td>
###xml 4142 4147 4130 4135 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">99.67</td>
###xml 4147 4158 4135 4146 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(95.35&#8211;100)</td>
###xml 4158 4163 4146 4151 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">99.49</td>
###xml 4163 4176 4151 4164 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(98.89&#8211;99.81)</td>
###xml 4139 4176 4127 4164 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">115</td><td rowspan="1" colspan="1">99.67</td><td rowspan="1" colspan="1">(95.35&#8211;100)</td><td rowspan="1" colspan="1">99.49</td><td rowspan="1" colspan="1">(98.89&#8211;99.81)</td></tr>
###xml 4176 4179 4164 4167 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">120</td>
###xml 4179 4184 4167 4172 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">99.85</td>
###xml 4184 4195 4172 4183 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(96.75&#8211;100)</td>
###xml 4195 4200 4183 4188 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">99.23</td>
###xml 4200 4213 4188 4201 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(98.42&#8211;99.70)</td>
###xml 4176 4213 4164 4201 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">120</td><td rowspan="1" colspan="1">99.85</td><td rowspan="1" colspan="1">(96.75&#8211;100)</td><td rowspan="1" colspan="1">99.23</td><td rowspan="1" colspan="1">(98.42&#8211;99.70)</td></tr>
###xml 4213 4216 4201 4204 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">125</td>
###xml 4216 4221 4204 4209 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">99.93</td>
###xml 4221 4232 4209 4220 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(97.79&#8211;100)</td>
###xml 4232 4237 4220 4225 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">98.86</td>
###xml 4237 4250 4225 4238 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(97.81&#8211;99.53)</td>
###xml 4213 4250 4201 4238 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">125</td><td rowspan="1" colspan="1">99.93</td><td rowspan="1" colspan="1">(97.79&#8211;100)</td><td rowspan="1" colspan="1">98.86</td><td rowspan="1" colspan="1">(97.81&#8211;99.53)</td></tr>
###xml 4250 4253 4238 4241 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">130</td>
###xml 4253 4258 4241 4246 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">99.97</td>
###xml 4258 4269 4246 4257 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(98.56&#8211;100)</td>
###xml 4269 4274 4257 4262 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">98.36</td>
###xml 4274 4287 4262 4275 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(97.04&#8211;99.26)</td>
###xml 4250 4287 4238 4275 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">130</td><td rowspan="1" colspan="1">99.97</td><td rowspan="1" colspan="1">(98.56&#8211;100)</td><td rowspan="1" colspan="1">98.36</td><td rowspan="1" colspan="1">(97.04&#8211;99.26)</td></tr>
###xml 4287 4290 4275 4278 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">135</td>
###xml 4290 4295 4278 4283 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">99.99</td>
###xml 4295 4306 4283 4294 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(99.11&#8211;100)</td>
###xml 4306 4311 4294 4299 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">97.71</td>
###xml 4311 4324 4299 4312 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(96.06&#8211;98.89)</td>
###xml 4287 4324 4275 4312 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">135</td><td rowspan="1" colspan="1">99.99</td><td rowspan="1" colspan="1">(99.11&#8211;100)</td><td rowspan="1" colspan="1">97.71</td><td rowspan="1" colspan="1">(96.06&#8211;98.89)</td></tr>
###xml 3991 4324 3979 4312 <tbody xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><td rowspan="1" colspan="1">100</td><td rowspan="1" colspan="1">97.42</td><td rowspan="1" colspan="1">(86.90&#8211;100)</td><td rowspan="1" colspan="1">99.88</td><td rowspan="1" colspan="1">(99.66&#8211;99.97)</td></tr><tr><td rowspan="1" colspan="1">105</td><td rowspan="1" colspan="1">98.64</td><td rowspan="1" colspan="1">(90.67&#8211;100)</td><td rowspan="1" colspan="1">99.80</td><td rowspan="1" colspan="1">(99.48&#8211;99.94)</td></tr><tr><td rowspan="1" colspan="1">110</td><td rowspan="1" colspan="1">99.32</td><td rowspan="1" colspan="1">(93.37&#8211;100)</td><td rowspan="1" colspan="1">99.67</td><td rowspan="1" colspan="1">(99.23&#8211;99.89)</td></tr><tr><td rowspan="1" colspan="1">112</td><td rowspan="1" colspan="1">99.49</td><td rowspan="1" colspan="1">(94.62&#8211;100)</td><td rowspan="1" colspan="1">99.61</td><td rowspan="1" colspan="1">(99.87&#8211;99.10)</td></tr><tr><td rowspan="1" colspan="1">115</td><td rowspan="1" colspan="1">99.67</td><td rowspan="1" colspan="1">(95.35&#8211;100)</td><td rowspan="1" colspan="1">99.49</td><td rowspan="1" colspan="1">(98.89&#8211;99.81)</td></tr><tr><td rowspan="1" colspan="1">120</td><td rowspan="1" colspan="1">99.85</td><td rowspan="1" colspan="1">(96.75&#8211;100)</td><td rowspan="1" colspan="1">99.23</td><td rowspan="1" colspan="1">(98.42&#8211;99.70)</td></tr><tr><td rowspan="1" colspan="1">125</td><td rowspan="1" colspan="1">99.93</td><td rowspan="1" colspan="1">(97.79&#8211;100)</td><td rowspan="1" colspan="1">98.86</td><td rowspan="1" colspan="1">(97.81&#8211;99.53)</td></tr><tr><td rowspan="1" colspan="1">130</td><td rowspan="1" colspan="1">99.97</td><td rowspan="1" colspan="1">(98.56&#8211;100)</td><td rowspan="1" colspan="1">98.36</td><td rowspan="1" colspan="1">(97.04&#8211;99.26)</td></tr><tr><td rowspan="1" colspan="1">135</td><td rowspan="1" colspan="1">99.99</td><td rowspan="1" colspan="1">(99.11&#8211;100)</td><td rowspan="1" colspan="1">97.71</td><td rowspan="1" colspan="1">(96.06&#8211;98.89)</td></tr></tbody>
###xml 3915 4324 3903 4312 <table xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Plasma GRN level cut-point (ng/ml)</th><th colspan="2" rowspan="1">Sensitivity (95% CI)<xref ref-type="table-fn" rid="TF4"><sup>a</sup></xref></th><th colspan="2" rowspan="1">Specificity (95% CI)<xref ref-type="table-fn" rid="TF4"><sup>a</sup></xref></th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">100</td><td rowspan="1" colspan="1">97.42</td><td rowspan="1" colspan="1">(86.90&#8211;100)</td><td rowspan="1" colspan="1">99.88</td><td rowspan="1" colspan="1">(99.66&#8211;99.97)</td></tr><tr><td rowspan="1" colspan="1">105</td><td rowspan="1" colspan="1">98.64</td><td rowspan="1" colspan="1">(90.67&#8211;100)</td><td rowspan="1" colspan="1">99.80</td><td rowspan="1" colspan="1">(99.48&#8211;99.94)</td></tr><tr><td rowspan="1" colspan="1">110</td><td rowspan="1" colspan="1">99.32</td><td rowspan="1" colspan="1">(93.37&#8211;100)</td><td rowspan="1" colspan="1">99.67</td><td rowspan="1" colspan="1">(99.23&#8211;99.89)</td></tr><tr><td rowspan="1" colspan="1">112</td><td rowspan="1" colspan="1">99.49</td><td rowspan="1" colspan="1">(94.62&#8211;100)</td><td rowspan="1" colspan="1">99.61</td><td rowspan="1" colspan="1">(99.87&#8211;99.10)</td></tr><tr><td rowspan="1" colspan="1">115</td><td rowspan="1" colspan="1">99.67</td><td rowspan="1" colspan="1">(95.35&#8211;100)</td><td rowspan="1" colspan="1">99.49</td><td rowspan="1" colspan="1">(98.89&#8211;99.81)</td></tr><tr><td rowspan="1" colspan="1">120</td><td rowspan="1" colspan="1">99.85</td><td rowspan="1" colspan="1">(96.75&#8211;100)</td><td rowspan="1" colspan="1">99.23</td><td rowspan="1" colspan="1">(98.42&#8211;99.70)</td></tr><tr><td rowspan="1" colspan="1">125</td><td rowspan="1" colspan="1">99.93</td><td rowspan="1" colspan="1">(97.79&#8211;100)</td><td rowspan="1" colspan="1">98.86</td><td rowspan="1" colspan="1">(97.81&#8211;99.53)</td></tr><tr><td rowspan="1" colspan="1">130</td><td rowspan="1" colspan="1">99.97</td><td rowspan="1" colspan="1">(98.56&#8211;100)</td><td rowspan="1" colspan="1">98.36</td><td rowspan="1" colspan="1">(97.04&#8211;99.26)</td></tr><tr><td rowspan="1" colspan="1">135</td><td rowspan="1" colspan="1">99.99</td><td rowspan="1" colspan="1">(99.11&#8211;100)</td><td rowspan="1" colspan="1">97.71</td><td rowspan="1" colspan="1">(96.06&#8211;98.89)</td></tr></tbody></table>
###xml 4324 4325 4312 4313 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 4324 4487 4312 4475 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="34"><sup>a</sup>Estimate based on assumption of normally distributed GRN levels after square root transformation. Confidence intervals constructed by parametric bootstrap method.</p>
###xml 4324 4487 4312 4475 <fn xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="TF4"><p textid="34"><sup>a</sup>Estimate based on assumption of normally distributed GRN levels after square root transformation. Confidence intervals constructed by parametric bootstrap method.</p></fn>
###xml 4324 4487 4312 4475 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><fn id="TF4"><p textid="34"><sup>a</sup>Estimate based on assumption of normally distributed GRN levels after square root transformation. Confidence intervals constructed by parametric bootstrap method.</p></fn></table-wrap-foot>
###xml 3817 4487 3805 4475 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T3" position="float"><label>Table 3</label><caption><p textid="33">Estimated sensitivity and specificity of the <italic>GRN</italic> ELISA assay using different cut-off values</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Plasma GRN level cut-point (ng/ml)</th><th colspan="2" rowspan="1">Sensitivity (95% CI)<xref ref-type="table-fn" rid="TF4"><sup>a</sup></xref></th><th colspan="2" rowspan="1">Specificity (95% CI)<xref ref-type="table-fn" rid="TF4"><sup>a</sup></xref></th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">100</td><td rowspan="1" colspan="1">97.42</td><td rowspan="1" colspan="1">(86.90&#8211;100)</td><td rowspan="1" colspan="1">99.88</td><td rowspan="1" colspan="1">(99.66&#8211;99.97)</td></tr><tr><td rowspan="1" colspan="1">105</td><td rowspan="1" colspan="1">98.64</td><td rowspan="1" colspan="1">(90.67&#8211;100)</td><td rowspan="1" colspan="1">99.80</td><td rowspan="1" colspan="1">(99.48&#8211;99.94)</td></tr><tr><td rowspan="1" colspan="1">110</td><td rowspan="1" colspan="1">99.32</td><td rowspan="1" colspan="1">(93.37&#8211;100)</td><td rowspan="1" colspan="1">99.67</td><td rowspan="1" colspan="1">(99.23&#8211;99.89)</td></tr><tr><td rowspan="1" colspan="1">112</td><td rowspan="1" colspan="1">99.49</td><td rowspan="1" colspan="1">(94.62&#8211;100)</td><td rowspan="1" colspan="1">99.61</td><td rowspan="1" colspan="1">(99.87&#8211;99.10)</td></tr><tr><td rowspan="1" colspan="1">115</td><td rowspan="1" colspan="1">99.67</td><td rowspan="1" colspan="1">(95.35&#8211;100)</td><td rowspan="1" colspan="1">99.49</td><td rowspan="1" colspan="1">(98.89&#8211;99.81)</td></tr><tr><td rowspan="1" colspan="1">120</td><td rowspan="1" colspan="1">99.85</td><td rowspan="1" colspan="1">(96.75&#8211;100)</td><td rowspan="1" colspan="1">99.23</td><td rowspan="1" colspan="1">(98.42&#8211;99.70)</td></tr><tr><td rowspan="1" colspan="1">125</td><td rowspan="1" colspan="1">99.93</td><td rowspan="1" colspan="1">(97.79&#8211;100)</td><td rowspan="1" colspan="1">98.86</td><td rowspan="1" colspan="1">(97.81&#8211;99.53)</td></tr><tr><td rowspan="1" colspan="1">130</td><td rowspan="1" colspan="1">99.97</td><td rowspan="1" colspan="1">(98.56&#8211;100)</td><td rowspan="1" colspan="1">98.36</td><td rowspan="1" colspan="1">(97.04&#8211;99.26)</td></tr><tr><td rowspan="1" colspan="1">135</td><td rowspan="1" colspan="1">99.99</td><td rowspan="1" colspan="1">(99.11&#8211;100)</td><td rowspan="1" colspan="1">97.71</td><td rowspan="1" colspan="1">(96.06&#8211;98.89)</td></tr></tbody></table><table-wrap-foot><fn id="TF4"><p textid="34"><sup>a</sup>Estimate based on assumption of normally distributed GRN levels after square root transformation. Confidence intervals constructed by parametric bootstrap method.</p></fn></table-wrap-foot></table-wrap>
###xml 211 219 <span type="species:ncbi:9606">patients</span>
###xml 343 350 <span type="species:ncbi:9606">patient</span>
###xml 467 475 <span type="species:ncbi:9606">patients</span>
###xml 1649 1657 <span type="species:ncbi:9606">patients</span>
###xml 1824 1832 <span type="species:ncbi:9606">patients</span>
###xml 1895 1903 <span type="species:ncbi:9606">patients</span>
###xml 1968 1976 <span type="species:ncbi:9606">patients</span>
###xml 2352 2360 <span type="species:ncbi:9606">patients</span>
###xml 2585 2592 <span type="species:ncbi:9606">patient</span>
###xml 2665 2673 <span type="species:ncbi:9606">patients</span>
###xml 2756 2764 <span type="species:ncbi:9606">patients</span>
###xml 3239 3247 <span type="species:ncbi:9606">patients</span>
We then determined whether the levels of GRN in plasma could be used to distinguish GRN loss-of-function mutation carriers from non-GRN carriers in our FTLD series. Using a GRN ELISA we analysed a subset of 207 patients with FTLD from our consecutive cohort with plasma availability, including seven loss-of-function GRN mutation carriers and patient NGR247 carrying the partial GRN deletion, p.A472_Q548del. A significant reduction in GRN levels was observed in all patients carrying GRN loss-of-function mutations to about one third of the level observed in non-GRN carriers (Fig. 1; Table 2). GRN levels ranged from 53 to 94 ng/ml (mean value +/- SD: 68 +/- 16 ng/ml) in mutation carriers, while non-GRN carriers showed levels from 115 to 386 ng/ml (mean value +/- SD: 220 +/- 47 ng/ml). Interestingly, GRN levels were variable among GRN mutation carriers with slightly higher expression in NGR019 (88 ng/ml) carrying the p.A9D mutation in the signal peptide sequence and NGR247 (94 ng/ml) carrying p.A472_Q548del, compared to the typical frameshift and nonsense mutation carriers (Fig. 2). Based on our data alone, any cut-off value between 94 and 115 ng/ml is associated with crude estimates of both sensitivity and specificity of 100%. By assuming normality of GRN levels after a square root transformation, we were able to explore continuous estimates of sensitivity and specificity with different cut-off values (Table 3). A cut-off value of 112 ng/ml maximized the average of the estimates of sensitivity and specificity. GRN levels in 70 control individuals ranged from 138 to 376 ng/ml (mean value +/- SD: 228 +/- 50 ng/ml) comparable to patients with FTLD without GRN mutations (Fig. 1). As expected, normal GRN expression (259 ng/ml) was observed in our MAPT mutation carrier. Figure 1Plasma GRN levels in FTLD patients and control individuals. Plasma GRN protein levels (ng/ml) in patients with FTLD carrying loss-of-function GRN mutations (n = 8), FTLD patients without GRN mutations (n = 191) and healthy control individuals (n = 70). Each data point represents an individual. Plasma levels are significantly decreased in loss-of-function GRN mutation carriers compared to non-GRN mutation carriers (P < 0.001; Mann-Whitney test). For each group the median plasma level is indicated with a wide horizontal line. For larger groups (FTLD patients without GRN mutation carriers and healthy control individuals) 25% and 75% quantiles are shown with short horizontal lines.Figure 2Specific plasma GRN levels in all types of GRN mutations. GRN expression is plotted for each patient with FTLD from our cohort carrying a GRN mutation. Black bars represent patients with FTLD carrying pathogenic GRN loss-of-function mutations; grey bars represent patients with FTLD carrying GRN mutations with unknown significance. The dashed line is the cut-off value for pathogenic GRN loss-of-function mutations based on the complete FTLD series and the black line indicates the minimum GRN expression identified in our control cohort (Fig. 1). Missense mutations p.R19W and p.C139R show GRN levels below the range detected in control individuals and may induce a partial loss of GRN function.Table 2Summary of plasma GRN expression levels in patients with FTLDPlasma GRN levels (ng/ml)VariableNMedianIQRRangeP-valueLoss-of-function GRN mutationa    Yes85957-8153-94<0.001    No191213186-249115-386Genderb    Male95203183-233130-3700.0011    Female96233196-258115-386Family historyb    Yes74219185-249115-3860.80    No117211186-250130-307Clinical FTLD subtypesb    bvFTD62218189-258143-3700.61    PNFA27216187-260115-386    SD40212187-235137-278    FA37205180-248127-310    CBS25230188-249130-360aPatients carrying GRN mutations with unknown pathogenic nature were excluded.bPatients carrying GRN mutations were excluded.Table 3Estimated sensitivity and specificity of the GRN ELISA assay using different cut-off valuesPlasma GRN level cut-point (ng/ml)Sensitivity (95% CI)aSpecificity (95% CI)a10097.42(86.90-100)99.88(99.66-99.97)10598.64(90.67-100)99.80(99.48-99.94)11099.32(93.37-100)99.67(99.23-99.89)11299.49(94.62-100)99.61(99.87-99.10)11599.67(95.35-100)99.49(98.89-99.81)12099.85(96.75-100)99.23(98.42-99.70)12599.93(97.79-100)98.86(97.81-99.53)13099.97(98.56-100)98.36(97.04-99.26)13599.99(99.11-100)97.71(96.06-98.89)aEstimate based on assumption of normally distributed GRN levels after square root transformation. Confidence intervals constructed by parametric bootstrap method.
###end p 27
###begin p 28
###xml 142 145 142 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 157 158 157 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 187 190 187 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 202 203 202 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 244 245 244 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 357 360 357 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 395 398 395 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 418 419 418 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 571 574 571 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 26 34 <span type="species:ncbi:9606">patients</span>
###xml 97 105 <span type="species:ncbi:9606">patients</span>
###xml 170 178 <span type="species:ncbi:9606">patients</span>
###xml 554 562 <span type="species:ncbi:9606">patients</span>
Plasma GRN levels in FTLD patients and control individuals. Plasma GRN protein levels (ng/ml) in patients with FTLD carrying loss-of-function GRN mutations (n = 8), FTLD patients without GRN mutations (n = 191) and healthy control individuals (n = 70). Each data point represents an individual. Plasma levels are significantly decreased in loss-of-function GRN mutation carriers compared to non-GRN mutation carriers (P < 0.001; Mann-Whitney test). For each group the median plasma level is indicated with a wide horizontal line. For larger groups (FTLD patients without GRN mutation carriers and healthy control individuals) 25% and 75% quantiles are shown with short horizontal lines.
###end p 28
###begin p 29
###xml 43 46 43 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 138 141 138 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 212 215 212 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 292 295 292 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 385 388 385 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 491 494 491 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 540 546 540 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 592 595 592 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 684 687 684 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 93 100 <span type="species:ncbi:9606">patient</span>
###xml 173 181 <span type="species:ncbi:9606">patients</span>
###xml 264 272 <span type="species:ncbi:9606">patients</span>
Specific plasma GRN levels in all types of GRN mutations. GRN expression is plotted for each patient with FTLD from our cohort carrying a GRN mutation. Black bars represent patients with FTLD carrying pathogenic GRN loss-of-function mutations; grey bars represent patients with FTLD carrying GRN mutations with unknown significance. The dashed line is the cut-off value for pathogenic GRN loss-of-function mutations based on the complete FTLD series and the black line indicates the minimum GRN expression identified in our control cohort (Fig. 1). Missense mutations p.R19W and p.C139R show GRN levels below the range detected in control individuals and may induce a partial loss of GRN function.
###end p 29
###begin p 30
###xml 43 51 <span type="species:ncbi:9606">patients</span>
Summary of plasma GRN expression levels in patients with FTLD
###end p 30
###begin p 31
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 19 22 19 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
aPatients carrying GRN mutations with unknown pathogenic nature were excluded.
###end p 31
###begin p 32
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 19 22 19 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
bPatients carrying GRN mutations were excluded.
###end p 32
###begin p 33
###xml 45 48 45 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
Estimated sensitivity and specificity of the GRN ELISA assay using different cut-off values
###end p 33
###begin p 34
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
aEstimate based on assumption of normally distributed GRN levels after square root transformation. Confidence intervals constructed by parametric bootstrap method.
###end p 34
###begin p 35
###xml 38 41 38 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 212 215 212 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 607 613 607 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 20 28 <span type="species:ncbi:9606">patients</span>
###xml 195 203 <span type="species:ncbi:9606">patients</span>
Within the group of patients carrying GRN mutations with unknown pathogenic nature, NGR139 (p.C139R) and NGR022 (p.R19W) showed relatively low expression of GRN, in the range of the lowest 3% of patients without GRN mutations (p.C139R: 124.2 ng/ml; p.R19W: 135.9 ng/ml) and below the GRN levels observed in control individuals. Although these GRN levels fall outside the range of the typical loss-of-function mutations, these mutations may induce a partial loss-of-function. In contrast, the GRN levels in the other missense mutation carriers and silent mutation carriers were well within the normal range (Fig. 2).
###end p 35
###begin p 36
###xml 20 23 20 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 245 246 237 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 256 263 248 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 760 767 752 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 853 856 845 848 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 882 885 874 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 626 634 <span type="species:ncbi:9606">patients</span>
###xml 702 710 <span type="species:ncbi:9606">patients</span>
In the group of non-GRN mutation carriers, a significant gender difference in plasma GRN expression levels was observed with higher levels in females (mean value +/- SD: 230 +/- 48 ng/ml) compared to males (mean value +/- SD: 210 +/- 44 ng/ml) (P < 0.001; Table 2). In exploratory analysis of subgroups by age and gender, it appeared that GRN levels may decrease with age in males, while remaining constant in females, however these findings did not reach significance (data not shown). Also, the gender difference was not confirmed in our control cohort. No significant differences in GRN plasma levels were observed between patients with a positive and negative family history of dementia or between patients with each of the five clinical subtypes of FTLD (Table 2). Also, no correlation between GRN expression levels and the age of disease onset in GRN mutation carriers or non-GRN mutation carriers was observed.
###end p 36
###begin p 37
###xml 38 41 38 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 280 283 280 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 500 503 500 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 633 636 633 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 665 668 665 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 688 689 688 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 699 705 699 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 708 716 708 716 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3</label>
###xml 766 769 766 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 797 800 797 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 889 892 889 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 971 974 971 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 994 995 994 995 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1015 1018 1015 1018 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 1038 1039 1038 1039 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1067 1070 1067 1070 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 1082 1083 1082 1083 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1165 1168 1165 1168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 1217 1220 1217 1220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 1232 1233 1232 1233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 716 1386 716 1386 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="38">Plasma GRN levels in symptomatic and asymptomatic <italic>GRN</italic> mutation carriers in three <italic>GRN</italic> mutation families. Plasma GRN protein levels (ng/ml) in patients and relatives of three <italic>GRN</italic> mutation families ascertained in Mayo Jacksonville and Rochester: Symptomatic <italic>GRN</italic> mutation carriers (<italic>n</italic> = 9), asymptomatic <italic>GRN</italic> mutation carriers (<italic>n</italic> = 6) and relatives without <italic>GRN</italic> mutations (<italic>n</italic> = 12). Plasma levels are significantly decreased in symptomatic and asymptomatic <italic>GRN</italic> mutation carriers compared to relatives without <italic>GRN</italic> mutations (<italic>P</italic> &lt; 0.001; Mann&#8211;Whitney test). Each data point represents an individual. For each group, the median plasma level is indicated with a wide horizontal line.</p>
###xml 716 1386 716 1386 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="38">Plasma GRN levels in symptomatic and asymptomatic <italic>GRN</italic> mutation carriers in three <italic>GRN</italic> mutation families. Plasma GRN protein levels (ng/ml) in patients and relatives of three <italic>GRN</italic> mutation families ascertained in Mayo Jacksonville and Rochester: Symptomatic <italic>GRN</italic> mutation carriers (<italic>n</italic> = 9), asymptomatic <italic>GRN</italic> mutation carriers (<italic>n</italic> = 6) and relatives without <italic>GRN</italic> mutations (<italic>n</italic> = 12). Plasma levels are significantly decreased in symptomatic and asymptomatic <italic>GRN</italic> mutation carriers compared to relatives without <italic>GRN</italic> mutations (<italic>P</italic> &lt; 0.001; Mann&#8211;Whitney test). Each data point represents an individual. For each group, the median plasma level is indicated with a wide horizontal line.</p></caption>
###xml 1386 1386 1386 1386 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="awn352f3"/>
###xml 708 1386 708 1386 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F3" position="float"><label>Figure 3</label><caption><p textid="38">Plasma GRN levels in symptomatic and asymptomatic <italic>GRN</italic> mutation carriers in three <italic>GRN</italic> mutation families. Plasma GRN protein levels (ng/ml) in patients and relatives of three <italic>GRN</italic> mutation families ascertained in Mayo Jacksonville and Rochester: Symptomatic <italic>GRN</italic> mutation carriers (<italic>n</italic> = 9), asymptomatic <italic>GRN</italic> mutation carriers (<italic>n</italic> = 6) and relatives without <italic>GRN</italic> mutations (<italic>n</italic> = 12). Plasma levels are significantly decreased in symptomatic and asymptomatic <italic>GRN</italic> mutation carriers compared to relatives without <italic>GRN</italic> mutations (<italic>P</italic> &lt; 0.001; Mann&#8211;Whitney test). Each data point represents an individual. For each group, the median plasma level is indicated with a wide horizontal line.</p></caption><graphic xlink:href="awn352f3"/></fig>
###xml 200 208 <span type="species:ncbi:9606">patients</span>
###xml 396 400 <span type="species:ncbi:162683">Mayo</span>
###xml 418 422 <span type="species:ncbi:162683">Mayo</span>
###xml 857 865 <span type="species:ncbi:9606">patients</span>
###xml 926 930 <span type="species:ncbi:162683">Mayo</span>
To further characterize the effect of GRN mutations on the levels of GRN in plasma, we performed a GRN ELISA on nine affected (one proband included in the consecutive FTLD series and eight additional patients) and 18 unaffected at-risk individuals from three previously published GRN mutation families with typical loss-of-function mutations (p.T52HfsX2, p.T382SfsX30 and p.R493X) ascertained at Mayo Jacksonville and Mayo Rochester. Six of the 18 asymptomatic at-risk individuals were identified as GRN mutation carriers using DNA sequencing analyses. We observed significantly lower GRN levels in both symptomatic and asymptomatic GRN mutation carriers, than non-GRN mutation carriers (P < 0.001; Fig. 3). Figure 3Plasma GRN levels in symptomatic and asymptomatic GRN mutation carriers in three GRN mutation families. Plasma GRN protein levels (ng/ml) in patients and relatives of three GRN mutation families ascertained in Mayo Jacksonville and Rochester: Symptomatic GRN mutation carriers (n = 9), asymptomatic GRN mutation carriers (n = 6) and relatives without GRN mutations (n = 12). Plasma levels are significantly decreased in symptomatic and asymptomatic GRN mutation carriers compared to relatives without GRN mutations (P < 0.001; Mann-Whitney test). Each data point represents an individual. For each group, the median plasma level is indicated with a wide horizontal line.
###end p 37
###begin p 38
###xml 50 53 50 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 81 84 81 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 173 176 173 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 255 258 255 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 278 279 278 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 299 302 299 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 322 323 322 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 351 354 351 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 366 367 366 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 449 452 449 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 501 504 501 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 516 517 516 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 141 149 <span type="species:ncbi:9606">patients</span>
###xml 210 214 <span type="species:ncbi:162683">Mayo</span>
Plasma GRN levels in symptomatic and asymptomatic GRN mutation carriers in three GRN mutation families. Plasma GRN protein levels (ng/ml) in patients and relatives of three GRN mutation families ascertained in Mayo Jacksonville and Rochester: Symptomatic GRN mutation carriers (n = 9), asymptomatic GRN mutation carriers (n = 6) and relatives without GRN mutations (n = 12). Plasma levels are significantly decreased in symptomatic and asymptomatic GRN mutation carriers compared to relatives without GRN mutations (P < 0.001; Mann-Whitney test). Each data point represents an individual. For each group, the median plasma level is indicated with a wide horizontal line.
###end p 38
###begin p 39
###xml 60 61 60 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 201 204 201 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 350 353 350 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 550 553 550 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 631 637 631 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 639 643 639 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">2008</xref>
###xml 771 774 771 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 4 12 <span type="species:ncbi:9606">patients</span>
###xml 505 512 <span type="species:ncbi:9606">patient</span>
###xml 576 583 <span type="species:ncbi:9606">patient</span>
All patients in our FTLD cohort with GRN levels <112 ng/ml (n = 8), were explained by pathogenic loss-of-function mutations identified by direct sequencing. Since the presence of a partial or complete GRN gene deletion/duplication is expected to have a similar effect on GRN expression, e.g. the loss of 50% of GRN, these data suggest the absence of GRN copy-number mutations in our series. To further confirm this finding, we performed a GRN ELISA on plasma obtained from the previously published French patient carrying a near complete deletion of GRN including exons 1-11 [patient II.4 from original publication (Rovelet-Lecrux et al., 2008)] and two unrelated French control individuals. These analyses showed a strongly reduced expression of GRN (86.2 ng/ml) in the GRN deletion carrier, compared to control individuals (196.6 and 263.2 ng/ml).
###end p 39
###begin p 40
###xml 287 290 287 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 694 700 694 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 702 706 702 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">1984</xref>
###xml 778 781 778 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 53 61 <span type="species:ncbi:9606">patients</span>
###xml 131 138 <span type="species:ncbi:9606">patient</span>
###xml 421 428 <span type="species:ncbi:9606">patient</span>
###xml 736 744 <span type="species:ncbi:9606">patients</span>
Next, we performed a GRN ELISA in a population of 72 patients with a clinical diagnosis of early-onset Alzheimer's disease. In one patient, strongly reduced GRN expression levels (74 ng/ml) were observed and sequencing analyses showed a novel loss-of-function mutation c.592_593delAG in GRN exon 5, which is expected to result in a shift of the normal reading frame and a premature termination codon (p.R198GfsX19). This patient presented at the age of 63 years with an amnestic syndrome which was confirmed on neuropsychology. MRI showed mild atrophy including frontal atrophy. No family history of dementia was reported. He met NINCDS/ADRDA criteria for probable Alzheimer's disease (McKhann et al., 1984). GRN levels in the other 71 patients with Alzheimer's disease without GRN mutations ranged from 143 to 368 ng/ml (mean value +/- SD: 238 +/- 53 ng/ml), comparable to GRN levels in control individuals.
###end p 40
###begin p 41
###xml 232 235 232 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 206 214 <span type="species:ncbi:9606">patients</span>
Finally, to gain more insight into the processing of GRN and to determine which GRN species are detected by the ELISA, we performed GRN Western blot analyses on plasma samples and brain homogenates of FTLD patients with and without GRN mutations. These studies indicated that the antibodies used in the ELISA could only detect full-length GRN, no intermediate GRN fragments or recombinant GRN cleavage products.
###end p 41
###begin title 42
Discussion
###end title 42
###begin p 43
###xml 37 40 37 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 148 151 148 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 182 188 182 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 190 195 190 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">2008a</xref>
###xml 294 297 294 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 376 382 376 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 384 388 384 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">2008</xref>
###xml 492 495 492 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 565 568 565 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
The range of mutations identified in GRN over the past 2 years established GRN haploinsuffiency as the uniform disease mechanism underlying FTLD in GRN mutation carriers (Gijselinck et al., 2008a). Microarray data further showed significantly reduced GRN mRNA expression in peripheral blood in GRN loss-of-function mutation carriers compared to non-mutation carriers (Coppola et al., 2008). These findings raised the important question as to whether expression of GRN in plasma could predict GRN mutation status and could be used as a biological marker to identify GRN mutation carriers.
###end p 43
###begin p 44
###xml 208 211 208 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 237 240 237 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 417 420 417 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 565 571 565 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 573 577 573 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">2006</xref>
###xml 580 583 580 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 760 763 760 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 924 930 924 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 932 936 932 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">2006</xref>
###xml 948 954 948 954 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 956 960 956 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">2006</xref>
###xml 962 966 962 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">2008</xref>
###xml 984 990 984 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 992 996 992 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">2006</xref>
###xml 1005 1011 1005 1011 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1013 1017 1013 1017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">2007</xref>
###xml 1025 1031 1025 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1033 1037 1033 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">2007</xref>
###xml 1191 1194 1191 1194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 1229 1232 1229 1232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 1252 1253 1252 1253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1472 1475 1472 1475 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 1583 1586 1583 1586 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 1614 1617 1614 1617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 1792 1798 1792 1798 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1800 1804 1800 1804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">2008</xref>
###xml 1942 1945 1942 1945 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 1994 1997 1994 1997 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 2315 2322 2315 2322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">Table 3</xref>
###xml 86 94 <span type="species:ncbi:9606">patients</span>
###xml 110 114 <span type="species:ncbi:162683">Mayo</span>
###xml 281 289 <span type="species:ncbi:9606">patients</span>
###xml 371 379 <span type="species:ncbi:9606">patients</span>
###xml 550 558 <span type="species:ncbi:9606">patients</span>
###xml 1327 1335 <span type="species:ncbi:9606">patients</span>
To answer this question, we first studied a large consecutive series of clinical FTLD patients ascertained at Mayo Jacksonville, for which DNA and plasma samples were available. Direct sequencing analyses of GRN identified six different GRN loss-of-function mutations in nine FTLD patients explaining the disease in 4.1% (9/219) of the population and 5.7% (5/87) of FTLD patients with a positive family history. This GRN mutation frequency is very similar to our previously reported mutation frequency of 4.8% in an unbiased subpopulation of US FTLD patients (Gass et al., 2006). GRN mutations included typical nonsense and frameshift mutations as well as the previously reported p.A9D mutation in the signal peptide sequence of GRN, and a partial deletion of GRN exon 11, which extends from 15-bp upstream of exon 11 to 177-bp in exon 11 and is predicted to result in an in-frame deletion of exon 11 (p.A472_Q548del) (Gass et al., 2006; Mukherjee et al., 2006, 2008; Pickering-Brown et al., 2006; Kelley et al., 2007; Spina et al., 2007). GRN expression studies in the complete FTLD cohort using a GRN ELISA demonstrated that plasma GRN levels were strongly reduced in all loss-of-function GRN mutation carriers compared to non-GRN mutation carriers (P < 0.001). Even though we observed a wide range in GRN expression in FTLD patients and control individuals, all mutation carriers showed significantly reduced GRN levels to about one third of the levels observed in non-GRN carriers and control individuals. In our series, a plasma GRN cut-off value of 112 ng/ml distinguished all GRN mutation carriers from non-GRN carriers and we therefore expect it to have close to 100% sensitivity and specificity in future samples. These results are in line with a recently published study by Ghidoni et al. (2008) who established that in an Italian FTLD population a GRN cut-off level of 110.9 ng/ml was 92.8% specific and 100% sensitive to identify GRN mutations. However, since there were only eight GRN mutation carriers in our FTLD population, further carriers will need to be assessed to more definitively decide on the optimal cut-off; in the meantime it may be prudent to use a higher threshold than 112 ng/ml to be more certain of a high sensitivity, without materially lowering specificity. For example, examining Table 3 we see that a cut-off value of 135 ng/ml has a lower confidence limit for sensitivity of >99%, and this is achieved with an estimated specificity of 97.7%.
###end p 44
###begin p 45
###xml 108 111 108 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 231 234 231 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 396 399 396 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 60 68 <span type="species:ncbi:9606">patients</span>
###xml 133 140 <span type="species:ncbi:9606">patient</span>
###xml 195 202 <span type="species:ncbi:9606">patient</span>
###xml 317 324 <span type="species:ncbi:9606">patient</span>
Interestingly, we showed strongly reduced GRN expression in patients carrying all types of loss-of-function GRN mutations, including patient NGR019 carrying the p.A9D signal peptide mutation and patient NGR247 carrying the partial GRN deletion, p.A472_Q548del. We also confirmed similar low levels of GRN in a French patient with clinical Parkinson's disease carrying a near complete deletion in GRN.
###end p 45
###begin p 46
###xml 49 52 49 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 231 234 231 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
Next, by analysing unaffected relatives carrying GRN mutations, we showed that the GRN reduction is independent of the disease status, suggesting that the GRN ELISA could also function as a diagnostic tool to identify asymptomatic GRN mutation carriers.
###end p 46
###begin p 47
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 86 89 86 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 275 278 275 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 297 306 297 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 354 360 354 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 362 366 362 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">2008</xref>
###xml 379 385 379 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 387 392 387 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">2008a</xref>
###xml 789 795 789 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 797 801 797 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">2008</xref>
###xml 812 818 812 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 820 824 820 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">2008</xref>
###xml 1621 1630 1621 1630 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 1689 1692 1689 1692 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 2019 2022 2019 2022 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 2212 2215 2200 2203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 46 54 <span type="species:ncbi:9606">patients</span>
###xml 152 160 <span type="species:ncbi:9606">patients</span>
###xml 640 647 <span type="species:ncbi:9606">patient</span>
###xml 693 700 <span type="species:ncbi:9606">patient</span>
###xml 872 879 <span type="species:ncbi:9606">patient</span>
###xml 1403 1410 <span type="species:ncbi:9606">patient</span>
###xml 1539 1547 <span type="species:ncbi:9606">patients</span>
GRN sequencing analyses in our cohort of FTLD patients also identified four different GRN missense mutations with unknown pathogenic nature in six FTLD patients. The plasma GRN levels in these missense mutation carriers generally supported the previously predicted effect on GRN function based on in silico structural protein modeling analyses (Brouwers et al., 2008; Gijselinck et al., 2008a). Mutation p.C139R was predicted to be likely pathogenic because of a destabilizing effect on the granulin-fold by disrupting one of the cysteine disulfide bridges. This mutation had been previously reported in an Italian early-onset familial FTD patient and a Belgian late-onset Alzheimer's disease patient, while absent in >900 control individuals that were analysed by us and others (Bernardi et al., 2008; Brouwers et al., 2008). We observed this mutation in a familial FTLD patient diagnosed with FA at the age of 76 years. His problem began with language difficulty including expression and comprehension. Sentence repetition was preserved. Picture description was normal except for some mild anomia. MRI showed mild non-asymmetrical atrophy. PET analyses showed hypometabolism in the left parietotemporal area and neuropsychometric testing indicated deficits in language, frontal function and preserved memory. In line with the predictions, low amounts of GRN were measured in the plasma sample of this patient (124 ng/ml), supporting the pathogenic potential of this mutation through a partial loss of GRN function. In contrast, all four patients carrying missense mutations p.A324T and p.R433W, which were predicted by in silico analyses to be tolerated, and both carriers of the silent GRN mutations (p.H447 and p.P578) showed GRN plasma levels within the normal range. Although we cannot exclude the possibility that these mutations abolish GRN function without reducing the overall expression of GRN, these findings suggested that plasma GRN levels may be a valuable tool in predicting the pathogenic potential of GRN mutations. We propose that individuals carrying intermediate levels of GRN (approximately110-140 ng/ml) undergo additional genetic testing to determine the presence of potential pathogenic GRN missense mutations.
###end p 47
###begin p 48
###xml 121 124 121 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 146 152 146 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 154 158 154 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">2007</xref>
###xml 225 228 225 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 474 480 474 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 482 486 482 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">2007</xref>
###xml 653 656 653 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 73 81 <span type="species:ncbi:9606">patients</span>
###xml 560 568 <span type="species:ncbi:9606">patients</span>
###xml 676 683 <span type="species:ncbi:9606">patient</span>
Previous studies have reported clinical Alzheimer's disease diagnoses in patients carrying loss-of-function mutations in GRN (Boeve, 2007; Kelley et al., 2007). In a clinicopathological study, we performed on the most common GRN mutation worldwide, p.R493X, 10% of the mutation carriers received a primary clinical diagnosis of Alzheimer's disease and memory impairment was the second most common initial clinical symptom, affecting 30% of the mutation carriers (Rademakers et al., 2007). In this study, using our GRN ELISA as a screening tool, we analysed 72 patients with clinically diagnosed early-onset probable Alzheimer's disease for mutations in GRN and identified one patient (1.4% of the population) carrying a loss-of-function mutation. If a disease modifying treatment for either Alzheimer's disease or FTLD becomes available in the future, then, based on the finding above and knowing that that FTLD usually starts early, one could make the case that it would be reasonable to screen early-onset probable Alzheimer's disease cases with a plasma measure for GRN.
###end p 48
###begin p 49
###xml 103 106 91 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 307 310 295 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 338 344 326 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 346 350 334 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">2008</xref>
###xml 430 433 418 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 459 465 447 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 467 471 455 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2006</xref>
###xml 676 679 664 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 796 799 784 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 1217 1223 1205 1211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1225 1229 1213 1217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">2002</xref>
###xml 1247 1251 1235 1239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">2003</xref>
###xml 1259 1265 1247 1253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1267 1271 1255 1259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">2007</xref>
###xml 107 115 <span type="species:ncbi:9606">patients</span>
###xml 782 790 <span type="species:ncbi:9606">patients</span>
In our study, plasma GRN levels were approximately75% reduced in mutation carriers with respect to non-GRN patients and controls, which is significantly more than expected based on the haploinsufficiency disease mechanism. A similar reduction in GRN expression was recently reported in an Italian series of GRN mutation carriers (Ghidoni et al., 2008). In contrast, only 35-50% reductions in GRN mRNA levels have been reported in GRN mutation carriers (Baker et al., 2006). These findings, together with the fact that we established that only full-length GRN and no granulins or intermediate GRN fragments can be detected by our ELISA, predict an unbalanced GRN metabolism in GRN mutation carriers, whereby the processing of GRN into granulins is increased. This would suggest that patients with GRN mutations may specifically lack full-length GRN, while maintaining normal levels of granulins. This is an interesting finding which may have implications for future therapeutic strategies, especially since GRN and the proteolytically derived granulin fragments each have distinct biological properties, e.g. GRN functions as a growth factor or anti-inflammatory agent, while granulin peptides boost inflammation (Zhu et al., 2002; He and Bateman, 2003; Ahmed et al., 2007). In future experiments, detailed biochemical analysis of the secretion and proteolytic processing of GRN in mutation carriers and control individuals will be essential.
###end p 49
###begin p 50
###xml 215 218 215 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 305 308 305 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 442 445 442 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRN</italic>
###xml 53 61 <span type="species:ncbi:9606">patients</span>
###xml 228 236 <span type="species:ncbi:9606">patients</span>
In conclusion, this large study of GRN expression in patients with FTLD, Alzheimer's disease and control individuals provides strong support for the use of a GRN ELISA as a reliable and inexpensive tool to identify GRN mutation patients and carriers. Moreover, compared to classical mutation screening of GRN by sequencing analyses, a GRN ELISA has the important advantage of identifying individuals carrying all types of mutations including GRN deletions.
###end p 50
###begin title 51
Funding
###end title 51
###begin p 52
###xml 0 29 0 29 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">National Institutes of Health</grant-sponsor>
###xml 31 42 31 42 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P50 AG16574</grant-num>
National Institutes of Health (P50 AG16574 to R.C.P., D.W.D, B.B., N.R.G-R and R.R.); the Pacific Alzheimer's Disease Research Foundation (C06-01 to D.W.D and R.R.)
###end p 52
###begin title 53
References
###end title 53
###begin article-title 54
Progranulin in frontotemporal lobar degeneration and neuroinflammation
###end article-title 54
###begin article-title 55
Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
###end article-title 55
###begin article-title 56
Granulins: the structure and function of an emerging family of growth factors
###end article-title 56
###begin article-title 57
A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series
###end article-title 57
###begin article-title 58
A novel deletion in progranulin gene is associated with FTDP-17 and CBS
###end article-title 58
###begin article-title 59
Novel PSEN1 and PGRN mutations in early-onset familial frontotemporal dementia
###end article-title 59
###begin article-title 60
Parkinson-related dementias
###end article-title 60
###begin article-title 61
Alzheimer and Parkinson diagnoses in progranulin null mutation carriers in an extended founder family
###end article-title 61
###begin article-title 62
Genetic variability in progranulin contributes to risk for clinically diagnosed Alzheimer disease
###end article-title 62
###begin article-title 63
Gene expression study on peripheral blood identifies progranulin mutations
###end article-title 63
###begin article-title 64
Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21
###end article-title 64
###begin article-title 65
Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration
###end article-title 65
###begin article-title 66
Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration
###end article-title 66
###begin article-title 67
Granulin mutations associated with frontotemporal lobar degeneration and related disorders: an update
###end article-title 67
###begin article-title 68
Progranulin locus deletion in frontotemporal dementia
###end article-title 68
###begin article-title 69
The logopenic/phonological variant of primary progressive aphasia
###end article-title 69
###begin article-title 70
Frontotemporal dementia
###end article-title 70
###begin article-title 71
Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis
###end article-title 71
###begin article-title 72
Progranulin is a mediator of the wound response
###end article-title 72
###begin article-title 73
Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17
###end article-title 73
###begin article-title 74
Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations
###end article-title 74
###begin article-title 75
Frontotemporal lobar degeneration and ubiquitin immunohistochemistry
###end article-title 75
###begin article-title 76
Prominent phenotypic variability associated with mutations in Progranulin
###end article-title 76
###begin article-title 77
Progranulin null mutations in both sporadic and familial frontotemporal dementia
###end article-title 77
###begin article-title 78
Frontotemporal lobar degeneration with motor neuron disease-type inclusions predominates in 76 cases of frontotemporal degeneration
###end article-title 78
###begin article-title 79
Dementia lacking distinctive histology (DLDH) revisited
###end article-title 79
###begin article-title 80
###xml 128 133 <span type="species:ncbi:9606">human</span>
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of department of health and human services task force on Alzheimer's Disease
###end article-title 80
###begin article-title 81
Clinical and pathological diagnosis of frontotemporal dementia: report of the work group on Frontotemporal Dementia and Pick's disease
###end article-title 81
###begin article-title 82
Progranulin mutations in primary progressive aphasia: the PPA1 and PPA3 families
###end article-title 82
###begin article-title 83
Primary progressive aphasia-a language-based dementia
###end article-title 83
###begin article-title 84
HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin
###end article-title 84
###begin article-title 85
Molecular characterization of novel progranulin (GRN) mutations in frontotemporal dementia
###end article-title 85
###begin article-title 86
Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria
###end article-title 86
###begin article-title 87
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
###end article-title 87
###begin article-title 88
Mutations in progranulin explain atypical phenotypes with variants in MAPT
###end article-title 88
###begin article-title 89
###xml 73 81 <span type="species:ncbi:9606">patients</span>
Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C->T (Arg493X) mutation: an international initiative
###end article-title 89
###begin article-title 90
The genetics of frontotemporal lobar degeneration
###end article-title 90
###begin article-title 91
###xml 36 44 <span type="species:ncbi:9606">patients</span>
Deletion of the progranulin gene in patients with frontotemporal lobar degeneration or Parkinson disease
###end article-title 91
###begin article-title 92
Corticobasal syndrome associated with the A9D Progranulin mutation
###end article-title 92
###begin article-title 93
Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival
###end article-title 93
###begin article-title 94
Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia
###end article-title 94
###begin article-title 95
Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair
###end article-title 95
###begin title 96
Abbreviations:
###end title 96
###begin p 97
behavioural variant frontotemporal dementia
###end p 97
###begin p 98
frontotemporal lobar degeneration
###end p 98
###begin p 99
progressive non-fluent aphasia
###end p 99
###begin p 100
semantic dementia
###end p 100
###begin p 101
single photon emission tomography
###end p 101

